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A story from the field
A male volleyball player, 24 years old, playing at the highest regional level comes to you as 
a clinician. He has suffered from periods of pain because of his jumper’s knee for 8 years 
now. There are only 4 weeks left of a long volleyball season. The most important play-
off games are coming up. He currently experiences some pain during offensive spikes 
and after a training or match his pain near the inferior pole of his patella is worst. Despite 
experiencing much pain, he manages to cope with participating in two training sessions 
and one match per week. However, pain hinders him to perform optimally during matches 
and training sessions. He is an important offensive player in the team; he, his coach and his 
team want him to perform during the play-offs to win the championship. He wants you to 
help him with his jumper’s knee.





This dissertation investigates the development and management of patellar tendinopathy, 
commonly known as jumper’s knee.1 Tendinopathy is an overuse injury of a tendon that occurs 
in loaded tendons of both the lower and upper limb.2 A tendon is the connection between 
muscle and bone; the patellar tendon is different from most other tendons because it connects 
two osseous structures – the patella and tibia. Therefore, the patellar tendon is also called the 
patellar ligament. The patellar tendon needs to be able to withstand high loads to perform 
(explosive) movements such as jumping.
Patellar tendinopathy is characterised by load related focal pain near the apex of the patella.3 
Tendinopathies more distal in the patellar tendon or at the superior pole of the patella also occur, 
but are far less frequently seen.4 People with patellar tendinopathy mainly experience pain in the 
first 24 hours after (heavy) physical activity. The less severe cases do not experience pain during 
physical activity after warming-up but have pain later that day or the next day. Palpation of the 
tendon insertion at the inferior pole is often painful.
The introduction of this thesis starts with an insight into the impact of patellar tendinopathy, an 
explanation of a healthy tendon and pathophysiology of tendinopathy. Subsequently aetiology, 
imaging and treatment of patellar tendinopathy are described as background of the three specific 
aims of this thesis. The aims are proposed and the outline of the thesis is described last in this 
introduction.
Impact of patellar tendinopathy
A high prevalence of patellar tendinopathy is reported in the literature. Up to 45% of elite volleyball 
and 32% of elite basketball athletes suffer from this injury.5 In recreational athletes the prevalence 
varies from 3-14%. Prevalence of patellar tendinopathy is higher in recreational volleyball, handball 
and basketball athletes than in other sports such as soccer and field hockey.6
Patellar tendinopathy is an injury that is difficult to manage; one-third of the patients with 
patellar tendinopathy presenting to sport medicine clinics are not able to return to sport within 
6 months.7 The impact of this injury on sport and work participation can be substantial. In a 
15 year follow-up study, 53% of athletes with patellar tendinopathy stopped participating in their 
sport because of this injury.8 Up to 50% of patients with patellar tendinopathy with physically 
demanding professions are impaired because of their knee injury. Work is not only affected in 
patients with physically demanding professions, 8% of patients with office jobs are impaired in 
performing their job.9 Inability of a patient with patellar tendinopathy to participate in sports and 
work can negatively affect their quality of life. On top of that, an injury – especially chronic and 
recalcitrant injuries like tendinopathy – can result in an inability to be physically active for a long 
time, thus missing out on all the health benefits of being physically active.10,11 Moreover, an inactive 
lifestyle has links with all kinds of diseases like coronary heart disease, type II diabetes and cancer.12 
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Improving knowledge on development and treatment of injuries like patellar tendinopathy will 
therefore contribute to a healthy ageing population.
Healthy tendon
A normal tendon consists of extracellular matrix and a few cells (tenocytes). Tenocytes are spindle 
shaped and are located between collagen bundles. Collagen is the main component of the 
extracellular matrix. This is predominantly type I collagen, some type III collagen in the endotenon 
and other types are present in smaller quantities in a normal tendon. The collagen fibres are 
tightly packed, minimal intratendinous nerves are present and there is minimal vascularity in 
the tendon. A collagen fibril is the smallest entity of a tendon; fibrils are arranged in collagen 
fibres and fibre bundles surrounded by endotenon. Proteoglycans such as Decorin are important 
for the structure and interconnection of the fibrils. The hierarchical structure of a tendon is 
displayed in Figure 1. The patellar tendon inserts to the patella with a fibrocartilaginous insertion, 
this type of insertion can be characterised into four sections: tendon, uncalcified fibrocartilage, 
calcified fibrocartilage and bone.13,14 A (healthy) tendon can adapt to various forms of physical 
activity through communication of the cells and cell-driven adaptation of the matrix, this is called 
mechanotransduction.15
Pathophysiology
The precise pathophysiology of patellar tendinopathy is still unknown. It is known that pathological 
tendons have proliferation of cells with abnormally rounded nuclei, increased amount of ground 
substance/matrix proteins, disrupted collagen and abnormal ingrowths of vessels and nerves.17 
Many issues surrounding the pathophysiological processes during the development of patellar 
tendinopathy are still unclear. Previously tendinopathy was called tendinitis; a shift in the literature 
took place around the year 2000. As it was found that hardly any inflammation occurs in chronic 
tendinopathies and the tendon is mainly degenerative, several researchers advocated a name 
change to tendinopathy.18,19 Moreover, a chronic overuse injury of the patellar tendon has more 
associations with a tendinosis (degeneration) than a tendinitis (inflammation).
It is hypothesised that tensile loads20 and/or compression21 are responsible for the development 
of tendinopathies. Elastic energy storage during a stretch-shortening cycle in a tendon, for 
example during repetitive jumping, is a high tensile load.22 Compression mainly occurs in 
insertional tendinopathies near the bone-tendon junction.21 A bony prominence at the insertion, 
which serves as a fulcrum for the tendon, may cause this compression. In patellar tendinopathy, 
stress shielding of the affected part of the tendon (often dorsal side of the tendon)23 and/or the 
infrapatellar fatpad24 may also play a role in the development. Pain in patellar tendinopathy is 
also still poorly understood. Different hypotheses about the origin of patellar tendon pain exist; 
tendon pain has physiological as well as pathophysiological characteristics.25
Several researchers have tried to explain the pathophysiology of tendinopathy in a variety of 
models. Although these models have different views and assumptions, they are not mutually 




exclusive. A few examples of these models are the ‘iceberg’ model of Abate et al,26 that states 
that micro-ruptures and neurogenic inflammation exist before presentation of symptoms of 
tendinopathy; the ‘failed healing’ theory of Fu et al27, that proposes a 3-stage model in which 
multiple factors influence the tendon in 3 stages: injury, failed healing and eventually clinical 
presentation of symptoms;27 and a model by Arnoczky et al20 that emphasises the importance of 
under-stimulation in the development of tendinopathy.
Probably one of the easiest models to apply to clinical practice is the continuum model 
by Cook and Purdam.2 This model describes different phases of tendinopathy as a continuum 
with possible transitions between phases of tendinopathy: reactive, disrepair and degenerative 
(figure 2). A reactive tendinopathy is proposed to be a proliferative response of the cell and 
matrix resulting in a short-term adaptation to overload expressed by a relatively homogeneous 
thickening of the tendon. Tendon disrepair is also described as an attempt for tendon healing: an 
increase in the number of cells, increase in protein production and possibly increased vascularity 
with associated neural ingrowth occurs in this presentation. A separation of collagen and matrix 
disorganisation takes place in a tendon disrepair presentation. In the ‘end stage’ degenerative 
tendinopathy there is little capacity for reversibility. It is characterised by areas of cell death due 
to apoptosis, trauma or tenocyte exhaustion, the matrix has no consistency and may be filled 
with neovascularisation.2 Clinically, tendons can be classified into two presentations: reactive 
tendinopathy and degenerative tendinopathy. In general, reactive tendinopathy has a rapid onset 
and is more common in younger athletes (age 15-25 year). Degenerative tendinopathy is more 
common in athletes with a long history of symptoms who are older (age 30-60 year).
Figure 1. The organisation of tendon structure from collagen fibrils to the entire tendon (reproduced from 
Kannus, 2000 with permission of John Wiley and Sons)16




Relative overuse of the tendon may cause an imbalance between anabolic and catabolic processes 
in the extracellular matrix of the tendon.28 Many external as well as internal risk factors are linked to 
patellar tendinopathy. Important risk factors are male gender,29 high BMI,30,31 physically demanding 
work,9,32 reduced dorsiflexion range of the ankle,33,34 limited quadriceps and hamstring flexibility35 
and genetic polymorphisms (e.g. COL1A1 and COL5A1).36 Overuse through training volume and 
playing matches seem to be the most important risk factors.29 However, it is still not known what 
the critical tendon load is to develop pathology in the patellar tendon.
Imaging
Ultrasound imaging is often used to confirm the clinical diagnosis of patellar tendinopathy. It is a 
more accurate than MRI to confirm a clinically diagnosed patellar tendinopathy.37 A conventional 
ultrasound image can show anterior-posterior diameter, presence of a hypoechoic area, 
calcifications and peritendinous abnormalities. Doppler ultrasound can image vascularisation 
within the tendon. Although presence of ultrasound abnormalities in the tendon on ultrasound 
increases the risk of developing patellar tendinopathy,38,39 scientific evidence on the relationship 
Figure 2. Continuum model of tendinopathy (Cook & Purdam, 2009 with permission of BMJ Publishing 
Group Ltd)2




between pain and ultrasound findings is contradictory.40,41 Recently, new imaging techniques such 
as ultrasound tissue characterisation (UTC) have been developed.42 UTC seems to be valuable 
when studying tendon structure; however few studies have been conducted using this imaging 
technique.
Management
Despite increasing attention on patellar tendinopathy in the scientific literature over the last 
decades (61 Pubmed indexed articles on patellar tendinopathy from 1990-2000 and already 254 
from 2010 until 2015), it is still a difficult injury to treat. Therefore, many different treatment options 
are being used in clinical practice.
The in-season management of patellar tendinopathy is more challenging than off-season 
when less patellar tendon loading occurs.43 The treatment modality that has the most support 
in the existing literature is exercise.44 Programs with eccentric exercises are the most studied 
exercise programs. Early studies showed that an eccentric training protocol was promising for 
the treatment of patellar tendinopathy. A review on eccentric training for patellar tendinopathy 
showed that approximately 60% of the patients could return to pre-injury level of sport 
participation.45 However, when an eccentric exercise program is performed without adjustment of 
load (in-season), symptoms might not change or may even get worse.46,47 A lack of improvement of 
symptoms is likely to lead to less adherence to an exercise program and will reduce the chance of 
a successful treatment. To improve the in-season management of patellar tendinopathy, two new 
exercise-based physical therapy modalities for in-season management of patellar tendinopathy 
are proposed (isometric and isotonic exercise therapy). Their effectiveness in-season is still 
unknown and the effectiveness of an isometric exercise program has not been studied at all for 
tendinopathy treatment.
Next to exercise-based treatments, extracorporeal shockwave therapy,48 medication,49 
injections,50 open surgery51 and arthroscopic shaving52 are some of the other treatment options 
that are currently being used. Success rates of these treatments vary and have limited support 
of high quality evidence.53 A semi-invasive treatment option which gained popularity over the 
last decade is injection treatment. This thesis defines Injection treatment as injecting a certain 
volume of liquid in or close to the patellar tendon. Many different types of injection treatment with 
different rationales are currently being used. Effectiveness of injection treatments is still unclear 
and little is known about its combination with exercise based physical therapy.
Aims
New research on patellar tendinopathy is important because of its high prevalence, complex 
aetiology and pathophysiology, impact on activities of daily living and sports, and variable 
treatment results. The general aim of this thesis is to gain more insight in the development and 
management of patellar tendinopathy.
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Specific aims of this thesis are:
1. To determine the effect of loading on patellar tendon structure in athletes;
2. To determine the effect of two new exercise-based physical therapy modalities for in-season 
management of patellar tendinopathy on pain and tendon structure;
3. To determine the role of exercise-based physical therapy and injection in patellar tendinopathy 
treatment.
Thesis outline
The first aim – the effect of loading on tendon structure – is investigated in Chapter 2. A study 
on the response of the adolescent patellar tendon to 5 days of cumulative load during a volleyball 
tournament is presented in this chapter.
Chapter 3 and Chapter 4 investigate the second aim of this thesis. These chapters contain 
two studies determining the effect of two new exercise-based physical therapy modalities for 
in-season management of patellar tendinopathy on pain and tendon structure. In Chapter 3 the 
clinical effects of an isometric and isotonic exercise program are investigated in a randomised 
clinical trial in athletes with patellar tendinopathy who are training and competing during a 
season. Chapter 4 describes a study which investigated if tendon structure on UTC changes in PT 
patients after a 4-week exercise program which decreased pain.
The third aim is investigated in chapters 5 and 6. A systematic review on injection treatments 
to provide an overview of the current literature on injection treatments for patellar tendinopathy 
is presented in Chapter 5. Chapter 6 describes an exercise-based physical therapy program for 
patients with patellar tendinopathy after platelet-rich plasma injection based on evidence and 
best practice. Next to a description of the physical therapy program, the feasibility and first results 
of this exercise program in combination with a platelet-rich plasma injection are described. In the 
general discussion (Chapter 7) results of the studies and their practical implications are discussed 
and recommendations for further research are provided.
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Patellar tendinopathy (jumper’s knee) has a high prevalence in jumping athletes. Excessive 
load on the patellar tendon through high volumes of training and competition is an 
important risk factor. Structural changes in the tendon are related to a higher risk of 
developing patellar tendinopathy. The critical tendon load that affects tendon structure 
is unknown. The aim of this study was to investigate patellar tendon structure on each 
day of a 5-day volleyball tournament in an adolescent population (16-18 years).The right 
patellar tendon of 41 players in the Australian Volleyball Schools Cup (AVSC) was scanned 
with ultrasound tissue characterization (UTC) on every day of the tournament (Monday-
Friday). UTC can quantify structure of a tendon into four echo-types based on the stability 
of the echopattern. Generalized estimating equations (GEE) were used to test for change 
of echo-type I and II over the tournament days. Participants played between eight and 
nine matches during the tournament. GEE analysis showed no significant change of echo-
type percentages of echo-type I (Wald chi-square=4.603,df=4,p=.331) and echo-type II 
(Wald chi-square=6.070,df =4,p=.194) over time. This study shows that patellar tendon 
structure of 16-18 year old volleyball players is not affected during 5 days of cumulative 
loading during a volleyball tournament.
Van_Ark.indd   22 14-8-2015   16:25:53




Patellar tendinopathy, also known as jumper’s knee, is an overuse injury of the patellar tendon that 
causes load-related focal pain usually at the tendon insertion to the patella. Patellar tendinopathy 
causes pain and dysfunction predominantly in jumping athletes,1,2 which may result in cessation 
of sport.3 The prevalence in elite volleyball athletes is as high as 45%,4 while a prevalence of 14.4% 
has been reported in recreational volleyball players.2
Patellar tendinopathy is diagnosed clinically, and confirmed with ultrasound imaging or MRI. 
Although the presence of ultrasound abnormalities in a tendon is not directly correlated with 
pain,5,6 current literature suggests that athletes with structural changes in their tendon have a 
higher risk of developing patellar tendinopathy than athletes without structural changes.7–14
Tendon structure has been difficult to measure until recently, where higher level analysis of 
ultrasound images has allowed quantification of tendon structure. Kulig et al.15 used fast Fourier 
transformation of ultrasound images and showed that tendon structure on ultrasound (peak 
spatial frequency) could discriminate between athletes with and without patellar tendinopathy. 
Similarly, van Schie et al.16 developed an algorithmic enhanced ultrasound analysis (ultrasound 
tissue characterization (UTC)) that can quantify the structure of a tendon based on the stability 
of the echopattern by calculating percentages of four echo-types (echo-type I being the most 
stable and echo-type IV being the least stable echo-type). UTC has been found to have good 
inter-tester reliability (ICC>0.9) in quantifying tendon structure.17 It has also been shown that UTC 
can discriminate between symptomatic and asymptomatic Achilles tendons,16 other validity data 
in humans are not yet available.
Many intrinsic and extrinsic factors may contribute to patellar tendinopathy and structural 
change. Extrinsic factors, especially excessive load through a high volume of training and 
competition, seem to be the most important risk factors.18 The amount of mechanical load placed 
on the tendon in sporting activities includes the intensity, volume, and frequency of patellar 
tendon loading, in this paper this will be called tendon load. It is unknown how much tendon 
load it takes to result in patellar tendinopathy and structural change. Insufficient rest of the tendon 
after an acute bout of load might result in cumulative structural changes.19 The acute response of 
a tendon to load in a competitive sport setting has only recently been investigated in the Achilles 
tendon; structural changes were reported two days after an Australian football match.20
Intrinsic factors to be considered include age, body composition and genetics.21,22 Of these 
factors, age seems to be an important factor. The relationship between structural changes and 
development of patellar tendinopathy symptoms seems more closely related in younger athletes 
than adults.14 Additionally, several studies show a high prevalence of patellar tendinopathy 
in teenage athletes, which might indicate that young athletes are prone to develop patellar 
tendinopathy.10,23,24 Another intrinsic risk factor to be considered is sex; a different prevalence has 
been reported between male and female athletes.2,4
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The response of the patellar tendon to tendon load, how tendons react to a bout of cumulative 
high load and if adolescents are susceptible to acute load-induced structural changes is unknown. 
To our knowledge, no previous studies investigated the response of a tendon during cumulative 
high bouts of loading during several days. The aim of this study was to investigate the response 
of the patellar tendon on UTC imaging during a five day volleyball tournament in an adolescent 
population (16-18 years old). Secondary aims of the study were to examine if patellar tendons 
of participants with hypoechoic abnormalities respond differently to tendon load than players 
without hypoechoic abnormalities and if the response to load varies by sex. A change in tendon 
structure during the tournament expressed by a decrease in echo-type I and a coinciding increase 
in echo-type II were hypothesised.
Materials and methods
Victorian teams playing in the top division in the Australian Volleyball Schools Cup (AVSC) 
were approached to participate in the study. AVSC is a competitive five day schools volleyball 
tournament. Six teams agreed to allow recruitment of players in their team. All participants 
provided informed consent and players aged 16 years or more were able to provide consent 
without parental approval. The study was approved by the Monash University Human Research 
Ethics Committee (MUHREC), Australia (CF13/2202 – 2013001164).
Standard anthropometric measures (height, weight, waist circumference) and a UTC scan were 
obtained at baseline (week before the tournament). Participants were asked if they had any knee 
pain and when answered ‘yes’, their knee was assessed by a physiotherapist to establish if the 
participant had patellar tendon pain or another knee injury. The clinical assessment was done 
by taking a history and testing the pain location on a single leg decline squat.25,26 Hypoechoic 
abnormalities in the patellar tendon were also recorded. Hypoechoic abnormality was defined 
as a hypoechoic zone visible on grey-scale ultrasound image of the tendon in the transverse and 
sagittal plane.
A UTC scan of the patellar tendon was performed on every day of the tournament. Furthermore, 
participants were asked about their knee pain on each day. When participants indicated that they 
had pain on a particular day, the single leg decline squat was used as a patellar tendon pain 
provocation test. Participants were asked to estimate the percentage of points that they were 
playing (not substituted) and the number of sets and points played by their team was recorded. 
On the final day, the question ‘What was last week like compared to physical activity loading your 
knee in the last three months?’ was asked to measure the subjective load on the knee. Participants 
were asked to answer this question on a 9-point global rating of change scale ranging from -4 
(very much less activity) to +4 (very much more activity).
The UTC scan was obtained during the tournament days at one of three playing venues. A UTC 
machine has an ultrasound probe (SmartProbe 12L5-V, Terason 2000+; Teratech, Burlington, 
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Maryland, USA) fixed in a tracking device (UTC Tracker, UTC Imaging, Stein, The Netherlands) to 
ensure a consistent transducer tilt angle in relation to the tendon. The tracker device moves the 
ultrasound probe automatically with a consistent speed perpendicular along the tendon long 
axis. An ultrasound image of the transverse plane of the tendon is captured every 0.2 mm over the 
length of the patellar tendon. The UTC software (UTC 2011, UTC Imaging) constructs the sagittal 
and coronal planes from the transverse images creating a 3D ultrasound data-block.17 The right 
knees of participants were scanned based on previous studies that showed that a majority of 
patellar tendinopathies in volleyball players occur in the right patellar tendon.27–30 Participants 
were scanned by one of two trained researchers (MvA, SD). Participants lay supine on a treatment 
bench; their knee was bent to an approximate 100˚ of knee flexion in which a clear image could 
be obtained with the ultrasound probe in the tracker perpendicular to the long axis of the tendon. 
A picture of the UTC scan set up is shown in figure 1.
The consistency of intensity and distribution of grey levels of images over a length of 4.8mm 
(25 images) was quantified by using computer algorithms. Based on the consistency, four echo-
types were created for every transverse image. The four echo-types range from the most stable 
echopattern (echo-type I) to the least stable echopattern (echo-type IV).16,17 The tendon was 
analysed from the apex of the patella to 20mm distally; percentages of these echo-types in this 
region of interest (RoI) were calculated. This RoI was chosen because pain and change of structure 
Figure 1. Setup of ultrasound tissue characterization scan of the patellar tendon
Van_Ark.indd   25 14-8-2015   16:25:54
Chapter 2
26
are normally localised in this area. To quantify echo-types in this area, tendon contours were 
marked by a trained researcher (MvA). All scans were de-identified before marking the contours 
to ensure the researcher was blind to participant and day of the scan. All scan contours were 
reviewed by both trained researchers to ensure consistency and poor quality scans were excluded. 
If consensus was not reached a third assessor made a final decision (6% of the scans).
This study examined echo-types I and II, because short-term changes in these echo-types have 
been shown in previous studies.20 Inter and intra observer reliability was assessed in 18 tendons.
Statistical analysis
Data were analysed for normality, distribution of echo-types I and II were found to be normal 
(Q-Q plots were assessed and Shapiro-Wilk tests were not significant). To establish if tendon 
structure was not fluctuating in the days before the tournament a paired T-test was run. Echo-type 
percentages from baseline and day 1 (Monday) measurements were compared.
Generalized estimating equations (GEE) were used to test for change of echo-type I and II over 
the tournament days. Separate models were run for echo-type I and echo-type II, with echo-type 
as dependent variable. Participant (ID number) was used as subject variable. Main effect of time 
(days of the tournament) was determined. An exchangeable working correlation matrix was used.
To test for the secondary aims of the study two models were run. In a second model 
hypoechoic abnormality was added to the first model; the main effect of hypoechoic abnormality 
and interaction effect time by hypoechoic abnormality were determined. A third model was run 
adding sex to the first model; its main effect together with the interaction effect time by sex were 
determined.
Results
Forty-one players from six different teams were recruited (Table 1). Two participants were excluded 
from all data analyses because of poor quality scans due to anisotropy or imaging artefacts, each 
day some scans were not analysed because of their quality (Table 2). No significant changes 
were found between echo-types on baseline and the first day of the tournament (echo-type I: 
t(27)=1.441, p=.161; echo-type II: t(27)=-1.083, p=.288).
Every team played eight or nine matches during the tournament, with a mean (SD) of 28.0(2.8) 
sets. The mean estimated number of points played (not substituted) by an individual athlete was 
871 ± 308 points. The subjective load on the knee during the tournament week compared to 
normal physical activity in the last three months was +1.8 ±1.6 on a 9-point global rating of change 
scale, indicating an increase in knee load. Four participants indicated that the tournament week 
was less physical activity loading their knee.
Eight participants reported patellar tendon pain at baseline; an additional seven reported 
patellar tendon pain on one or more days during the tournament. Fourteen of the 39 analysed 
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tendons showed hypoechoic abnormalities. Eleven of those 14 also reported pain on at least 
one day of the tournament. Four participants reported patellar tendon pain but did not show 
hypoechoic abnormalities. Twenty-one participants did not have patellar tendon pain or 
hypoechoic abnormalities.
Table 1. Baseline participant demographics and tendon characteristics
Measure Mean (SD)
Sex (m:w) 30:11
Age (yr) 17.2 (.8) 
Height (cm) 180.8 (7.3)
Weight (kg) 73.6 (11.2)
Number of times volleyball normal week 2.7 (1.5)
Hypoechoic abnormality (yes:no) 14:25
Patellar tendon pain before tournament (yes:no) 8:33
Patellar tendon pain at least one day of tournament (yes:no) 15:26
Echo-type I (%) n=30 58.7 (11.4)
Echo-type II (%) n=30 39.4 (9.8)
Echo-type III (%) n=30 1.6 (2.8)
Echo-type IV (%) n=30 .3 (.5)
Table 2. Number of scans completed each day of the tournament
Scans completed Scans included Scans excluded (low quality)a
Baseline 41/41 30/41 11/41
Monday 41/41 37/41 4/41
Tuesday 41/41 37/41 4/41
Wednesday 39/41 36/39 3/39
Thursday 40/41 32/40 8/40
Friday 38/41 32/38 6/38
Total 240/246 204/240 36/240
aIt was not possible to obtain a good scan on every day for two participants.
The echo-type percentages were calculated for each day of the tournament (Table 3). There 
was no significant change in echo-types over the five days of the study (echo-type I: Wald chi-
square=4.603, df =4, p =.331; echo-type II: Wald chi-square=6.070, df=4, p=.194 (figure 2)).
Van_Ark.indd   27 14-8-2015   16:25:54
Chapter 2
28
































































































































































































When hypoechoic abnormality was added to the model, a significant difference in echo-type I 
percentages in those with and without a hypoechoic abnormality was found (Wald chi-square = 
16.545, df=1 , p < .001), however this was not the case for echo-type II (Wald chi-square = 2.864, 
df = 1, p =.091). The way echo-type I (Wald chi-square = 3.853, df=4 , p =.426, figure 3) and echo-
type II (Wald chi-square =4.205, df=4, p =.379) changed over time was not significantly different 
between participants with and without hypoechoic abnormalities.
There were no significant differences between men and women for echo-type I (Wald chi-
square =1.818, df= 1, p = .178) and echo-type II (Wald chi-square = 3.401, df=1 , p=0.065). No 
difference between men and women in the way echo-type I percentages changed over time 
was found (Wald chi-square =3.457, df=4 , p =.484), however the way echo-type II percentages 
changed over time was significantly different for men and women (Wald chi-square =12.270, df=4, 
p =.015). They showed a similar minor increase over five days but day to day differences between 
men and women.
Reliability tested in 18 tendons showed an Intraclass Correlation Coefficient (ICC) for intra-
observer reliability of .82 (.66-.91) for echo-type I and .82 (.65-.91) for echo-type II with a mean 
difference of .6% and a SD of 5.8 for echo-type I and the same mean difference with a SD of 5.9 for 
echo-type II. The ICC for Inter observer reliability was .73 (.49-.91) with a mean difference of 2.2% 
for echo-type I and .73 (.49-.87) with a mean difference of 2.1% for echo-type II and a SD of 7.1 for 
both echo-types.
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Figure 2. Mean echo-type I and II percentages during tournament days
Discussion
This study investigated the effect on tendon structure of cumulative loading of the patellar 
tendon in a competitive high loading volleyball environment. This study showed no change in the 
echopattern of the patellar tendon of adolescent volleyball players over several days of cumulative 
loading during a volleyball tournament.
Based on previous studies we hypothesised change in tendon structure during the tournament 
expressed by a decrease in echo-type I and a coinciding increase in echo-type II. Achilles tendon 
structure on UTC after an Australian football match showed a decrease in echo-type  I and an 
increase in echo-type II after 2 days and a return to baseline values 4 days after the match.20 
A similar change in echo-types on UTC imaging was found in superficial digital flexor tendons 
of thoroughbred racehorses after loading.31 On the contrary, in recreational runners a difference 
in Achilles tendon structure on UTC imaging 2 and 4 days after a 10km run was not found.32 
The differences in findings between the studies can partly be explained by the difference in 
characteristics of the population. For example, Rosengarten et al. 20 investigated participants 
without Achilles tendon pain; other studies had subjects with tendon pain and abnormality in their 
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Figure 3. Mean echo-type I during tournament days for athletes with and without hypoechoic abnormalities 
at the start of the tournament
study. Another reason for different findings might be that this is the first UTC study on the patellar 
tendon; all other studies in humans have been performed on the Achilles tendon. It is likely that a 
different echo-type distribution exists between tendons; more research is needed to confirm this. 
Furthermore, the number of studies using UTC is still small. Values for percentages of echo-types I 
and II also differ per study performed with UTC. This study showed a higher percentage echo-
type II than any of the other studies using UTC.17,20,33,34 Rosengarten et al.20 showed a much higher 
percentage of echo-type I (92%) compared to this study, other studies showed lower percentages 
of echo-type I (34-49%). It is not possible to draw conclusion from these differences because UTC 
echo-type percentages are not comparable between studies unless exactly the same settings 
and UTC model have been used.
The results of the analyses with window size 25 were used in this study because this window 
size was also used in previous studies using UTC. Post-hoc analyses were also performed with 
window sizes 17 and 9. Change in echo-type percentages over time was not statistically different 
when analysis was performed using different window sizes (results not shown).
Van_Ark.indd   30 14-8-2015   16:25:54
Response of the patellar tendon to load
31
2
Many practical issues are involved in conducting a cohort study such as this where the 
environment is hard to control. However, the advantage of investigating the response of a real-
life tendon load outweighs the disadvantage of not being able to control all aspects. Access to 
players was sometimes hampered by coaches who wanted to instruct their players, who in turn 
were distracted by the tournament environment and the varying duration and venues of games. 
Finding a suitable time for a UTC scan of participants was one of the logistical challenges. Most 
scans were performed after the first match of the day. Although previous studies have shown an 
immediate decrease in anterior-posterior tendon diameter immediately post exercise,35 mechanical 
loading seems to take some time to exert effect on the structure of the tendon detected by UTC. 
A review on the response of a tendon to loading proposed that the metabolic response peaks 
only 24 hours after mechanical loading19 In addition, no changes in echo-types were found one 
day after an Australian football game, while there was a change in structure 2 days after a game.20 
As tendon structure is not immediately affected by exercise as tendon dimensions are, a variable 
time of day (of the UTC scans) will probably not have influenced the outcome for this study.
One of the most important variables to influence tendon structure is the load on the patellar 
tendon.18 Objective and subjective data showed that the tournament was a heavy load. We 
objectified the tendon load by calculating the total number of games, sets and points played 
including an individual estimation of total number of points played every day. This showed that 
on average 871 ± 308 points were actually played by an individual during the five days of the 
tournament over eight or nine matches. This was much more than the participants’ average 
number of times playing volleyball in a normal week (2.7 ± 1.5), often including only one match. 
To see if the participants also subjectively reported a high load a question was asked about their 
perceived knee loading during the tournament compared to a normal week. The results showed 
that most participants also perceived the tournament as a high load for their knees. Tendon 
load will have differed between participants of the study because the number of jumps varies 
between players;36 however the data showed that overall the tournament was a high load for the 
participants.
Pre-existing hypoechoic abnormalities on ultrasound might cause a different response of the 
patellar tendon to tendon load. Secondary analyses showed a significant difference in echo-type I 
percentage between athletes with and without hypoechoic abnormality. This confirms the relation 
between UTC and grey scale images. It also seems to be in line with Van Schie et al.,17 when taking 
into consideration that 11 of the 14 athletes also experienced patellar tendon pain. Van Schie 
et al.17 found that UTC discriminated between symptomatic and asymptomatic Achilles tendons. 
The difference between athletes with and without hypoechoic abnormalities was not significant 
for echo-type II, the difference in findings between echo-types I and II might be explained by the 
fact that symptomatic tendons show higher values of echo-type III and IV than controls.17 A lower 
percentage of echo-type I is not necessarily related to an increase in echo-type II. Although the 
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effect of pre-existing hypoechoic abnormalities over time was not significant, it is worth noticing 
that a tendency was seen for athletes with hypoechoic abnormalities to have a different response 
to tendon load than athletes without hypoechoic abnormalities. Cumulative tendon load seems 
to decrease the stability of echopatterns in athletes with existing hypoechoic abnormalities while 
athletes without abnormalities do not seem to change in overall echopattern. This seems to 
confirm previous findings that the presence of ultrasound changes increases the risk of developing 
patellar tendinopathy symptoms.7–14 When comparing participants with and without tendon pain 
at least one day of the tournament post-hoc, the same trend was observed. This is not surprising 
because 79% of the participants with hypoechoic abnormalities also reported tendon pain.
A significantly different change of echo-type II over time was found between men and women. 
When looking at the descriptive statistics, men and women seem to show the same trend for 
echo-type II percentages over time. Small day to day differences in echo-type II between male and 
female participants might have caused this significant finding by chance.
Limitations
A small number of scans were not good enough to analyse. Any ultrasound scan can vary in 
quality due to movement artefact, poor contact, hair, sweat and skin contour. A UTC scan of 
insufficient quality will have an overrepresentation of echo-types II, III and IV, because artefacts 
and not the structure of the tendon will cause inconsistencies. Therefore, poor quality scans (15%) 
were excluded from the analysis.
Furthermore, although previous studies on the Achilles tendon17 and current data on the 
patellar tendon show good reliability, we recommend further research on the reliability of the 
UTC in the patellar tendon on a larger population.
Perspective
This is the first study to investigate the effect of cumulative loading over several days in the patellar 
tendon in a real-life setting. Similar research has been completed in the Achilles tendon 20. The 
current study shows that five days of cumulative loading during a schools volleyball tournament is 
not detrimental for the structure of the tendon of 16-18 year old athletes. However, subgroups that 
show a decrease in structure of the echopattern after cumulative loading might exist, for example 
athletes with pre-existing hypoechoic abnormalities. An implication for volleyball organisations 
is that five days of consecutive loading is not detrimental to patellar tendon structure. Further 
research in this area should focus on different tendon loads and subgroups to find out what the 
critical load for tendon structure change is. This study should for example be replicated in elite 
athletes and a population with patellar tendinopathy to see if this shows different results.
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Objectives: Many athletes with patellar tendinopathy participate in sports with symptoms 
during or after activities. Current treatments do not decrease pain in-season; eccentric 
exercises in-season result in an increase in pain. This study examined if isometric and 
isotonic exercises relieved pain in competing athletes with patellar tendinopathy.
Design: Randomised clinical trial
Methods: Jumping athletes with patellar tendinopathy playing at least three times per 
week participated in this study. Athletes were randomised into an isometric or isotonic 
exercise group. The exercise programs consisted of four isometric or isotonic exercise 
sessions per week for 4 weeks. Pain during a single leg decline squat (SLDS) on a Numeric 
Rating Scale (NRS; 0-10) was used as the main outcome measure; measurements were 
completed at baseline and at 4-week follow-up.
Results: Twenty-nine athletes were included in this study. Median pain scores improved 
significantly over the 4-week intervention period in both the isometric group (Z=-2.527. 
p=0.012, r = -0.63) and isotonic group (Z=-2.952, p=0.003, r= -0.63). There was no significant 
difference in NRS pain score change (U = 29.0 p=0.208 r=0.29) between the isometric 
group (median (IQR), 2.5 (1-4.5)) and isotonic group (median (IQR), 3.0 (2-6)).
Conclusions: This is the first study to show a decrease in patellar tendon pain without a 
modification of training and competition load and the first study to investigate isometric 
exercises in a clinical setting. Both isometric and isotonic exercise programs are easy-to-
use exercises that can reduce pain from patellar tendinopathy for athletes in-season.
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Patellar tendinopathy, also known as jumper’s knee, is an overuse injury of the patellar tendon that 
causes pain and dysfunction. It is a common injury in sports that involve explosive movements 
that load the extensor mechanism of the knee.1 High prevalence rates are reported in jumping 
sports such as volleyball and basketball (45% and 32% in elite athletes respectively).1
Many different modalities are used for the treatment of patellar tendinopathy, however treatments 
like injections, shockwave and surgery require athletes to cease sporting activities.2–4 Exercise may 
be the best treatment for tendinopathies as histopathological changes and clinical improvements 
in pain and function have been demonstrated.5 Most studies have been conducted using eccentric 
exercise protocols6–8 and early studies showed positive results. However, eccentric exercises 
are not effective when used in-season and might even make symptoms worse in athletes with 
patellar tendinopathy.7,9,10 Moreover, when eccentric exercise was used prophylactically in-season 
in asymptomatic soccer players with pathology on imaging, there was a higher risk of developing 
a jumper’s knee.11
Many athletes play with jumper’s knee symptoms and pain negatively affects capacity to train 
and perform in matches. They cope with their injury because pain often decreases after warm-up 
but returns and is worse the day after activity. Isometric and isotonic exercises have the potential 
to decrease pain while continuing sport activities.12,13 Isotonic muscle contractions (heavy slow 
resistance training 3-5 times per week) resulted in a significant reduction in pain after a 12-week 
program.14,15 Isometric exercises have been found to decrease tendon pain in athletes with patellar 
tendinopathy in the short-term (45 minutes).16 It is unknown if isometric exercises can decrease 
tendon pain over a longer period of time and if repeated isometric exercises are beneficial.
The aim of this study was to examine whether isometric and isotonic exercises relieve pain in 
competing athletes with patellar tendinopathy. It was hypothesised that both isometric and 
isotonic exercises would decrease pain in athletes with patellar tendinopathy in-season and that 
isometric exercises would decrease patellar tendon pain more than isotonic exercises.
Methods
This study was a randomised trial of two interventions – participants were randomly assigned 
to one of two exercise intervention groups. The study was approved by the Monash University 
Human Research Ethics Committee (MUHREC), Australia (CF12/0230 – 2012000067). All participants 
provided written informed consent. This trial was registered in the Australian New Zealand Clinical 
Trial Registry (ACTRN12613000871741).
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Participants were volleyball and basketball players (16-32 years) playing or training at least 
three times per week, presenting with patellar tendinopathy diagnosed by an experienced 
physiotherapist. Inclusion criteria consisted of focal tendon pain at the inferior or superior pole of 
the patella and a history of exercise associated knee pain at the same spot. Exclusion criteria were 
existence of other knee pathology, previous patellar tendon rupture, previous patellar tendon 
surgery, inflammatory disorders, metabolic bone diseases, type II diabetes, use of fluroquinolones 
or corticosteroids in the last 12 months, known familial hypercholesterolemia and chronic pain 
conditions.
Players from Victorian volleyball leagues and basketball leagues who played or trained at 
least three  times per week were approached at their game or training venue. After baseline 
measurements were performed, participants were given an exercise program. Participants were 
randomised to an exercise program by the draw of a sealed opaque envelope from 40 identical 
envelopes that were randomised using a randomisation table created by computer software (20 
in each group). The program was demonstrated (including repetition maximum testing) at the 
gym where they were going to perform their exercises. Every week participants were followed-up 
in person or by phone, asking participants if they encountered any problems with the exercise 
program. After the 4-week exercise program baseline measurements were repeated.
Both groups performed a 4-week exercise program with exercises performed four times per week. 
The isometric and isotonic exercise program were matched for time under tension and rest. Pilot 
testing was used to ensure that the protocols were matched for rate of perceived exertion. The 
isometric exercise consisted of 5 x 45 second single leg isometric contractions of each leg on 
a leg extension machine. Isometric contractions were performed at 80% of maximal voluntary 
contraction with a knee joint angle of 60 degrees.
Isotonic exercise consisted of four sets of eight repetitions of single leg isotonic contractions of 
each leg on a leg extension machine. Isotonic contractions consisted of a three second concentric 
phase immediately followed by a four second eccentric phase and were performed on 80% 
of 8 repetitions maximum. After performing the exercises for each leg, participants rested for 
15 seconds before continuing with the first leg again.
Weight was increased by 2.5% every week if possible. If pain was experienced during an exercise 
or if participants were not able to complete their repetitions with proper execution (e.g. shaking 
during the contraction), they were instructed to lower the weight for the following repetitions and 
complete the entire session (equal time under tension). Audio files that counted the timing of the 
exercises were provided for use during their exercises to standardise the speed of repetition and 
rest and therefore time under tension for all participants.
The primary outcome measure was pain during a single leg decline squat (SLDS) scored on a 
numeric rating scale (NRS) (0 -10), which is a provocative clinical test to monitor tendon pain.17,18 
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The VISA-P, a questionnaire on pain and function of the knee,19 was also completed. The score 
on the VISA-P ranges from 0-100, 100 being a completely asymptomatic and fully functioning 
athlete. Participants were asked about their average tendon pain compared to the beginning of 
the exercise program on a global rating of change scale from very much worse (-4) to very much 
better (+4).
All outcome measures were administered at baseline and four weeks later at the end of the 
program. Only the worst knee was used in the analysis of the data in athletes with bilateral patellar 
tendinopathy.
NRS pain scores on the SLDS had a non-normal distribution, and non-parametric tests were used 
to test for differences. A Wilcoxon signed rank test was conducted to test for differences between 
baseline and follow-up measurements for NRS pain score during SLDS within each group. A Mann-
Whitney U test was used to test for differences between the isometric and isotonic intervention 
group. As secondary analyses, the same tests were performed for the VISA-P score. Analyses were 
conducted using IBM SPSS Statistics 20 software and an alpha of 0.05 was considered significant.
Results
Participants were included in the trial between August 2013 and July 2014 (Figure 1). Thirteen 
participants were randomised to the isometric group and 16 to the isotonic group. Group 
characteristics did not differ at baseline (Table 1) and mean adherence to the exercise program 
was 81%.








mean ± SD (range)
22.9 ± 4.9 (16-30) 23.1 ± 4.7 (17-32) 23.0 ± 4.7 (16-32)
Sex (male/female) 12/1 15/1 27/2
Duration of symptoms, months
mean ± SD (range) 
30.8 ± 26.1 (1-84) 39.6 ± 39.1 (1-120) 35.8 ± 33.8 (1-120)
BMI, kg/m2
mean ± SD (range)
23.7 ± 2.0 (19.8-26.5) 24.2 ± 3.7 (18.9-34.7) 24.0 ± 3.0 (18.9-34.7)
Unilateral/bilateral symptoms 6/7 7/9 13/16
Median pain scores improved significantly over the 4-week intervention period within the isometric 
group (Z=-2.527. p=0.012, r = -0.63) and within the isotonic group (Z=-2.952, p=0.003,  r= -0.63) 
(Table 2). There was no significant difference in NRS pain score change (U = 29.0 p=0.208 r=0.29) 
between the isometric group (median (IQR), 2.5 (1-4.5)) and isotonic group (median (IQR), 3.0 (2-6)) 
(Table 2). Median VISA-P scores also improved significantly over the 4 week intervention period 




























Did not play volleybal / 
basketball for 2 weeks
n = 2




(excluded in analysis for NRS pain)
n = 1
Missing VISA
(excluded in analysis for VISA)
n = 2
Figure 1. Flow chart of participants included in the trial
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within the isometric group (Z= -2.201, p=0.028, r=-0.55) and within the isotonic group (Z=-2.952, 
p=0.003, r=-0.66). There was no significant difference in VISA-P score change (U = 39.5 p=0.965 
r=-0.01) between the isometric group and isotonic group (Table 2). The median perceived global 
rating of change (-4 to +4) for tendon pain at follow-up compared to pre-intervention was +2.3 
(2.0-3.0).
Table 2. Main outcome measures at baseline and follow-up for the intervention groups and total population
Measurements Isometric group Isotonic group Total

















mean ± SD (range)
63.1 ± 22.4 (13-88)
n=8
66.6 ± 12.1 (46-83)
n=10
65.1 ± 16.9 (13-88)
n=18
VISA-P – 4wk
mean ± SD (range)
76.1 ± 17.0*^  (41-100)
n=8
78.7 ± 13.3* (59-98)
n=10
77.6 ± 14.7* (41-100)
n=18
Number of exercise performed 







Tendon pain change compared 
to pre-intervention on GRC







* Significant difference from baseline (p<0.05) ^Minimal clinical important difference from baseline
IQR = Inter quartile range, GRC = global rating of change scale
Discussion
This study showed a decrease in pain in athletes with patellar tendinopathy during a season with 
both isometric and isotonic exercises. The VISA-P also showed a significant improvement over 
time, which indicates that not only pain but also function of the knee improved in this population. 
No significant difference between the isometric and isotonic exercise group was found.
In the field of tendinopathy, where exercise is the primary and most effective treatment 
available,20,21 relatively few studies have been conducted on exercise programs for patellar 
tendinopathy.22 Improvements in pain have been reported when resistance exercise/training is 
used as rehabilitation. Kongsgaard et al14 showed a similar improvement in pain after 12 weeks 
of heavy slow resistance training as our study. After 6 weeks of a heavy slow isotonic exercise 
rehabilitation program, Cannell et al15 also found a decrease in pain. Other studies have focussed 
on eccentric exercises as rehabilitation, and these exercise protocols also relieved pain in non-
competing athletes.7,23,24 Eccentric exercise in-season has no effect or even worsens patellar 
tendinopathy symptoms.7,9,10 The findings of our study using isotonic and isometric exercise are in 
contrast with eccentric exercises in-season.
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Previous studies investigating short-term effects of isometric and isotonic exercises on (tendon) 
pain12,16 have found a decrease in pain post exercise. Isometric exercises resulted in a significant 
decrease in tendon pain and cortical inhibition (present at elevated levels in patellar tendinopathy); 
pain relief lasted for at least 45 minutes after isometric exercises, while a much smaller decrease in 
pain and no change in cortical inhibition was found after isotonic exercises.16 In contrast to these 
studies on the acute effects of isometric and isotonic exercise, our study found no difference 
between isotonic and isometric exercise after 4 weeks. Previous studies suggest it may be that 
isometric exercises have a greater effect in reducing acute pain, while isotonic exercise may 
cause a more gradual decrease in pain.15,16 How exercises affect pain is still unclear. An ongoing 
debate about pain in (patellar) tendinopathy exists; it is still unclear if pain is physiological or 
pathophysiological or a combination in patellar tendinopathy.25
Our study has an important contribution to the conservative management of patellar tendinopathy, 
in particular for in-season athletes with patellar tendinopathy. It also confirms the recent shift in 
the literature away from isolated eccentrics for the rehabilitation of patellar tendinopathy.26,27 More 
high quality research in this field is needed to find the best treatment strategy for every phase of 
tendinopathy.28
The dosage and type of exercise are important characteristics of an exercise program. A high 
percentage of repetition maximum (RM) has been used in our study for the isometric (80% 1RM) 
as well as the isotonic exercises (80% 8RM). Beneficial effects from physical training for tendons 
require high load per repetition.29 Furthermore, a high percentage of RM in leg extension exercises 
has been shown to improve muscle strength and neural activation.30 The leg extension machine 
was used to isolate the load through the rectus femoris and patellar tendon as much as possible. 
The optimal dosage and loading strategy to reduce tendon pain still have yet to be determined. 
Despite the positive effect of exercise for tendinopathy, both in research labs and in the clinic, the 
precise mechanism of effect has not yet been determined and further research is required.
Our study had relatively small numbers in the intervention groups. Despite small group sizes, 
we found significant improvements in pain scores in both groups. There were no data on which 
to base an a priori sample size calculation, as this was the first study to compare these exercise 
programs. The group sizes in this study are similar to other studies investigating exercise programs 
for patellar tendinopathy.22 The 4-week follow-up was relatively short as the study was designed to 
investigate if an (initial) decrease in patellar tendon pain could be achieved in competing athletes. 
Another limitation was that sessions were not supervised and no random checks for compliance 
in the gym were performed. This was a real-life study, supervision of all patients was therefore not 
feasible and it reflects what is done in clinical practice. The chance to successfully implement the 
exercise programs in practice with a high adherence of the patient might also be greater than in 
studies with a more controlled environment.
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This study was, to our knowledge, the first to find positive results for athletes with patellar 
tendinopathy without modification of the training and competition load and it was the first study 
to investigate isometric exercises in a clinical setting. Both isometric and isotonic exercise programs 
can reduce pain and improve function in athletes with patellar tendinopathy in-season.
Practical implications
• This study shows that isometric and isotonic exercises can decrease pain in athletes with 
patellar tendinopathy in-season.
• The exercises are easy to perform and also have the advantage over conventional eccentric 
training that they are less time-consuming for the athlete.
• The programs should be applied in a situation in which an athlete has pain in-season or in 
the first weeks after a patient comes to a sports medicine/physiotherapy clinic with patellar 
tendinopathy symptoms.
• Pain decrease in the relatively short term possibly increases the adherence of patients with a 
program and reduces the chance of transition to invasive and more expensive treatments.
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No change in tendon structure on ultrasound 
tissue characterization following a 4-week exercise 













Objectives: The aim of this study was to investigate the effects of a 4-week in-season 
exercise program of isometric or isotonic exercises on tendon structure and dimensions 
as quantified by UTC.
Background: Ultrasound imaging is often used to confirm the diagnosis of patellar 
tendinopathy. A novel imaging technique that enables quantification of tendon structure 
is Ultrasound Tissue Characterization (UTC). Limited data are available on the effect of 
in-vivo exercise programs on structural appearance of pathological patellar tendons.
Methods: Volleyball and basketball players (16-31 years) with clinically diagnosed patellar 
tendinopathy were randomized to a 4-week isometric or isotonic exercise program. The 
programs were designed to decrease patellar tendon pain. A baseline and 4-week UTC 
scan was used to evaluate change in tendon structure.
Results: No significant change in tendon structure or dimensions on UTC was detected 
after the exercise program, despite patellar tendinopathy symptoms improving. The 
percentage and mean cross-sectional area (mCSA) of aligned fibrillar structure (echo-
types I+II) (Z=-0.414,p=0.679) as well as disorganized structure (echo-types III + IV) 
(Z=-0.370,p=0.711) did not change over the 4-week exercise program. Change in tendon 
structure and dimensions on UTC did not differ significantly between the groups.
Conclusion: Structural properties and dimensions of the patellar tendon on UTC did not 
change after a 4-week isometric or isotonic exercise program for athletes with patellar 
tendinopathy in-season, despite an improvement of symptoms. Possible explanations for 
this are provided.
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Patellar tendinopathy (jumper’s knee) is an overuse injury of the patellar tendon that impacts on 
sport and work participation.1,2.The clinical diagnosis of patellar tendinopathy is often confirmed 
with ultrasound imaging, which has been shown to be relatively accurate in confirming patellar 
tendinopathy.3 However, conventional grayscale ultrasound has limited ability to measure 
tendon dimensions and monitor intra-tendinous changes in response to load. Only relatively 
gross measures such as cross sectional area, anterior-posterior diameter, and height and width 
of a hypoechoic zone can be measured. It is not possible to quantify tendon structure with 
conventional ultrasound.
Higher level analysis of ultrasound images has enabled quantification of tendon structure.4,5 
A relatively new imaging technique specifically designed for tendon is ultrasound tissue 
characterization (UTC, UTC imaging, Stein, The Netherlands). UTC provides a detailed view of a 
tendon in all planes and quantifies tendon structure by measuring stability of pixel brightness 
over contiguous transverse gray-scale images. UTC has been developed in veterinary medicine 
and tested against histomorphology of equine tissue.6 It has also been found to reliably quantify 
the stability of the echo-pattern in the human Achilles tendon and symptomatic tendons can be 
distinguished from non-symptomatic tendons using UTC.7 UTC may be able to detect more subtle 
changes in tendon structure than conventional ultrasound.8,9
Exercise-based treatment has the most evidence in the management of patellar tendinopathy.10 
The impact of exercise on tendon structure has not yet been elucidated. It has been shown that a 
pro-peptide marker of type I collagen in the peritendon is elevated after a single bout of exercise 
(three hours of running)11 as well as after a heavy resistance eccentric rehabilitation program of 
12 weeks.12 However, whether an increased type I collagen formation will lead to an adaptation in 
tendon structure is unclear, as tendon cells also have a capacity to prevent collagen fibrillogenesis 
within a cell.13 Limited data are available on the effect of in-vivo exercise programs on structural 
appearance of the patellar tendon in patients with patellar tendinopathy. Only one other study 
has investigated the effect of exercise on patellar tendon dimensions in patients with patellar 
tendinopathy.14 Doppler area and thickness of the patellar tendon decreased after a 12-week heavy 
slow resistance exercise program, but were not affected by a 12-week isolated eccentric exercise 
program. The effect of exercise programs on patellar tendon structure has not been investigated 
so far. Therefore, the aim of this study was to investigate the effect of a 4-week in-season exercise 
program on the structure and dimensions of the patellar tendon as quantified by UTC. This study 
investigated whether two exercise programs (isometric and isotonic exercises), designed to 
decrease patellar tendon pain, affected tendon structure or dimension on UTC.





Volleyball and basketball players (16-31 years) presenting with patellar tendinopathy who were 
training or playing at least three times per week were eligible for this study. Inclusion and exclusion 
criteria are presented in Table 1. The participants took part in a larger randomized clinical trial 
investigating the difference in effect on pain between an in-season 4-week isometric and an 
in-season 4-week isotonic exercise program. Detailed procedures of this trial have been reported 
elsewhere (van Ark et al., unpublished; Rio et al., unpublished). Before and after the exercise 
program, UTC scans of the patellar tendon were made. Written informed consent of participants 
was obtained before inclusion in the study and rights of the participants were protected. The 
study was approved by the Monash University Human Research Ethics Committee (MUHREC), 
Australia (CF12/0230 – 2012000067) and it was registered in the Australian New Zealand Clinical 
Trial Registry (ACTRN12613000871741).
Table 1. Inclusion and exclusion criteria
Inclusion criteria
• Patellar tendinopathy diagnosed by an experienced physiotherapist
• Focal pain at inferior or superior pole of the patella
• History of exercise associated knee pain
• Training or playing at least three times per week
Exclusion criteria
• Other knee pathology
• Previous patellar tendon rupture
• Previous patellar tendon surgery
• Inflammatory disorders
• Metabolic bone diseases
• Type II diabetes
• Use of fluorquinolone antibiotics or corticosteroids in last 12 months
• Known familial hypercholesterolemia
• Chronic pain conditions
Exercise programs
All exercises in both groups were performed on a leg extension machine. Five sets of 45 second 
single leg isometric holds were performed for both legs in the isometric exercise group during 
each session. The knee joint angle during the exercises was 60 degrees and contractions were 
executed at 80% of the maximal voluntary contraction weight.
The participants in the isotonic exercise group had to perform 4 sets of 8 repetitions single 
leg isotonic contractions for each leg per session. A repetition of an isotonic contraction started 
with a three second concentric phase followed by a four second eccentric phase. Exercises were 
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performed in a pain free range between 10-90 degrees of knee flexion at 80% of 8 repetitions 
maximum.
A set of exercises for both legs was followed by a rest interval of 15 seconds. Weights were 
increased by 2.5% every week if correct weight was available on the leg extension machine, if 
pain free and if no shaking of the muscles during the exercises took place. When participants 
experienced pain during an exercise or when their muscles started shaking, they were instructed 
to complete the session with a lower weight for the following repetitions. This ensured an equal 
time under tension for both groups. In addition to face-to-face explanation and instruction of 
the exercises by a physiotherapist at the gym, participants received an audio file with real-time 
instructions of the exercises and rest intervals to listen to during their exercises.
Outcome measures
UTC
A UTC scanner consists of an ultrasound probe (SmartProbe 10L5, Terason 2000; Teratech) secured 
in a tracking device (UTC Tracker, UTC Imaging) to ensure a consistent transducer tilt angle in 
relation to the tendon. The tracker device moves the ultrasound probe automatically with a 
constant speed perpendicular along the tendon long axis. An ultrasound image of the transverse 
plane of the tendon is captured every 0.2 mm over the length of the patellar tendon. The UTC 
software (UTC 2011, UTC Imaging) constructs the sagittal and coronal planes from the transverse 
images creating a 3D ultrasound data-block.7
Participants were scanned by one trained researcher (SD). The worst knee of participants (most 
pain on NRS (0-10) during single leg decline squat (SLDS)) was scanned.15 Participants lay supine 
on a treatment bench; their knee was bent to approximately 100˚ of knee flexion in which a clear 
image could be obtained with the ultrasound probe in the tracker perpendicular to the long axis 
of the tendon. Based on the consistency of intensity and distribution of gray levels of images 
over 4.8mm (25 images), four echo-types were created using computer algorithms. Echo-type I: 
intact and aligned tendon bundles; echo-type II: less integer and waving tendon bundles; echo-
type III: mainly fibrillar tissue; echo-type IV: a mainly amorphous matrix with loose fibrils, cells or 
fluid.4,7 A single ultrasound reflection that typically belongs to one interface structure is displayed 
as echo-type I or II (referred to as aligned fibrillar structure in this paper). Multiple reflections 
which interfere because of multiple interfaces are displayed as echo-types III and IV (referred to as 
disorganized structure in this paper).
Prior to analysis, the scans were de-identified to ensure the researcher was blind to participant 
and date of measurement. The tendon was analyzed over 30 mm starting from the disappearance 
of the apex of the patella. This region was selected as it coincides with the most common area of 
pain and pathology. Contours were manually selected around the border of the patellar tendon on 
the transverse images at regular intervals (no more than 5mm apart) over the length of the tendon. 
A consensus on the placement of contours between two experienced researchers (MvA and SD) 
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was reached. Based on these contours, the UTC software (UTC 2011, UTC Imaging) interpolated 
these defined contours to create a complete tendon volume where the proportions of each 
echo-type and total number of pixels were calculated. The percentages of each echo-type in the 
region of interest were calculated. Mean cross-sectional area (mCSA) of aligned fibrillar structure 
(echo-types I and II) and disorganized structure (echo-types III and IV) were calculated as well. UTC 
software provides the number of pixels and percentage of each echo-type for every transverse 
image. The CSA for each transverse image was calculated by multiplying the number of pixels 
by the area of the pixel (0.011mm2). The volume (mm3) of aligned fibrillar structure, disorganized 
structure and total tendon was calculated and divided by 30mm to provide the mCSA (mm2) for 
all parameters. This method has been described by Docking and Cook16 and has been validated 
against an ultrasound phantom of known volume. Furthermore, maximum thickness (anterior-
posterior diameter) of the patellar tendon was recorded.
Clinical outcome measures
Severity of patellar tendinopathy symptoms was quantified by pain measured with a numeric rating 
scale (NRS; 0-10) during a SLDS and the Victorian Institute of Sport Assessment – Patella (VISA-P) 
questionnaire. The single leg decline squat is a provocative clinical test that loads the patellar 
tendon in order to evaluate pain response of the patellar tendon.15,17,18 The VISA-P questionnaire is 
specifically designed to evaluate severity of symptoms, knee function and ability to participate in 
physical activity in athletes with patellar tendinopathy.19 It provides a score between 0 and 100, with 
a score of 100 representing a pain free and fully functioning athlete. Clinical outcome data – NRS 
pain (0-10) during the SLDS pre and post exercise program and VISA-P – are reported in a separate 
paper describing the clinical outcomes of this trial (van Ark et al, unpublished). Participants were 
also invited to be involved in a transcranial magnetic stimulation (TMS) sub-study. Furthermore, 
the immediate effects of the exercises are reported in a paper using the NRS pain score before 
and after every exercise session (Rio et al, unpublished). As the focus of the current paper is 
on tendon structure and dimensions, clinical outcomes will only briefly be mentioned in the 
results. The effect of these exercise programs on tendon structure and dimensions is important 
for the understanding of adaptation of the patellar tendon in response to treatment of patellar 
tendinopathy, and adds important information beyond the clinical outcome data.
Data analysis
As outcome measures were not normally distributed, Wilcoxon signed-rank tests were used to 
test for differences in the UTC echo-types, mCSA, thickness, NRS-pain during SLDS and VISA-P 
between baseline and follow-up measurements. A Mann-Whitney test was used to compare 
change in UTC outcome measures (UTC echo-types, mCSA and thickness) between the isometric 
and isotonic group.
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Participants were recruited by flyers including the most important inclusion criteria and by talking 
to teams playing or training three times per week. All athletes with patellar tendinopathy who 
were examined by the researchers matched the criteria and consented to participate in the trial. 
The number of athletes excluded from the study due to the presence of other knee injuries was 
not recorded. A total of 29 participants were included in the trial after the recruitment period, 
including participants with quadriceps tendinopathy at the superior pole of the patella. However, 
with current UTC techniques it is not possible to obtain a scan with sufficient quality of the 
quadriceps tendon superior to the patella. Therefore, no UTC scans could be obtained from three 
participants and these were excluded from the analysis (Figure 1). A flow chart of athletes with 
patellar tendinopathy participating in the study is presented in Figure 1. Participants were 16 men 
and 2 women with a mean (± SD) age of 22.7 (±4.7) years (range 16-31). Mean (± SD) BMI of the 
participants was 24.7 (±3.1) kg/m2 (range 20.4-34.7).
All outcome measures of the UTC scans did not show significant changes between baseline and 
follow-up measurements, with none of the parameters greater than previously reported minimum 
detectable differences (Table 2).16 There was no significant difference between the isometric and 
isotonic group for the change in echo-type I (U=28.0, p=0.286), echo-type II (U=29.0, p=0.328), 
echo-type III (U=33.0, p=0.534), echo-type IV (U=39.0, p=0.929), aligned fibrillar structure (U=33.5, 
p=0.563) and disorganized structure (U=33.0, p=0.534). Similarly, there was no significant change 
in mCSA of aligned fibrillar structure (U=35.0, p=0.657), mCSA of disorganized structure (U=34.0, 
p=0.594), mCSA (U=39.0, p=0.929) and tendon thickness (U=31.0, p=0.421) between groups. 
No difference in clinical outcomes between the groups after the 4-week exercise programs were 
found as well (van Ark et al, unpublished). A significant decrease in NRS-pain during the SLDS of 
(median (IQR)) 6.0 (4.0-6.3) to 2.0 (1.5-3.5) was found after the 4-week exercise program compared 
to baseline (Z=-3.634, p<0.001) (van Ark et al, unpublished). The VISA-P questionnaire showed 
a significant improvement after 4 weeks, from (median (IQR)) 68 (57-76) to 82 (73-88) (Z=-3.112, 
p=0.002) (van Ark et al, unpublished).




tendinopathy included in 
study (randomized)
n = 29
(isom n = 13, isot n = 16)
Excluded for analysis
(tendinopathy at superior
pole of patella, no UTC
possible) n = 3
(isom n = 1, isot n = 2)
Completed baseline 
UTC scan
n  = 26
(isom n = 12, isot n = 14)
Refused or not able to
complete exercise program
n = 5
(isom n = 3, isot n = 2)
Excluded (insucient
quality of UTC scan)
n = 3





(isom n = 8, isot n = 10)
Figure 1. Flow chart of athletes with patellar tendinopathy participating in the study 
(isom = isometric group, isot = isotonic group)
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Tendon structure, thickness and mean cross sectional area on UTC were not altered after a 4-week 
isometric or isotonic exercise program despite a significant decrease in pain. This is the first study 
to investigate the effects of a patellar tendinopathy treatment on patellar tendon structure with 
UTC.
The effect of treatments on patellar tendon structure and dimensions is still unclear. Although 
presence of ultrasound abnormalities increases the risk of developing patellar tendinopathy,20–24 
pain and ultrasound abnormalities do not have a one-to-one relationship.25 Results of previous 
studies are inconclusive regarding the relationship between clinical outcomes and ultrasound 
changes in lower limb tendinopathies.14,26–28 Only one in-vivo study on the effects of treatments on 
patellar tendon dimensions has been conducted in patients with patellar tendinopathy. This was 
a randomized controlled trial conducted by Kongsgaard et al, 14 which compared corticosteroid 
injections, isolated eccentric training and heavy slow resistance training in 52 recreational athletes 
with patellar tendinopathy. They found a decrease in anterior-posterior tendon diameter and color 
Doppler area in the heavy slow resistance and corticosteroid group after 12 weeks compared 
to baseline. Despite a similar decrease in pain between all groups, no change was found in the 
eccentric group. Patellar tendon cross sectional area was only increased in the eccentric training 
group.
Our results are in line with those of a prospective observational study of 23 chronic Achilles 
tendinopathy patients undertaking an eccentric training program.5 UTC echo-types did not change 
from baseline over the course of the 24 week training program, despite clinical improvement 
observed. They concluded that there was no short-term (24 weeks) increase in organized tendon 
structure after eccentric exercises.29 In contrast, an improvement in tendon structure on UTC was 
observed in 54 Achilles tendinopathy patients receiving either platelet-rich plasma (PRP) injection 
or placebo (saline) injection both combined with eccentric exercises. Tendon structure on UTC 
showed improvements in echo-types I+II and coincided with a significant decrease of echo-type III 
and IV after 24 weeks.30 However, the change in UTC echopattern was no different between the 
two groups. The changes in tendon structure on UTC seem to be related to the improvement in 
pain and function of these patients.31 The previous two UTC studies show contradictory evidence 
on the relation between clinical outcome and tendon structure on UTC. Results from our study 
support the theory that a decrease in pain does not necessarily mean a coinciding improvement 
in patellar tendon structure in the short term.
There are several possible explanations for the absence of an effect on structure in our study. 
One of the explanations is that changes in tendon structure take longer than 4 weeks to occur. 
Markers of anabolic and catabolic processes in the peri-tendon are in balance for the first 4 weeks 
of physical training, whereas after 4 weeks a net collagen synthesis occurs.32 However, changes to 
the tendon structure may not follow, tendon structure might take many months to improve26,33 if 
structure changes at all.28 This is confirmed by Heinemeier et al. who demonstrated that levels of 
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the radioisotope 14C in the core of Achilles tendons corresponded to atmospheric 14C levels during 
the first two decades of life among people living in regions where nuclear bomb testing occurred; 
in contrast hardly any 14C was present in muscle samples.34 The authors therefore concluded that 
renewal of adult core tendon tissue is extremely limited.34 Due to end of the season, participants 
have not been followed up over a longer period. Future research should investigate the effects 
over a longer period and the effects of longer exercise programs.
Another possible reason for the limited change in tendon structure observed in this study is 
that the tendon adapts to pathology by ensuring that sufficient levels of load-bearing aligned 
fibrillar structure is present.16 Docking & Cook16 compared the mCSA of aligned fibrillar structure on 
UTC (echo-types I and II) in the pathological and structurally normal patellar tendon. Interestingly, 
an increased mCSA of aligned fibrillar structure was observed in the pathological patellar tendon. 
The mCSA of aligned fibrillar structure in our study is similar to that reported in the structurally 
normal tendon.16 It was proposed that as the pathological patellar tendon contains sufficient levels 
of aligned fibrillar structure, remodeling of tendon structure is not required to obtain a positive 
clinical outcome. Moreover, Docking & Cook16 suggested that exercise based interventions may be 
efficacious by building load tolerance in the already present aligned fibrillar structure, improving 
muscular strength and capacity and/or changes to the central nervous system.35 The findings of 
the current study seem to support the hypothesis that structural improvements are not required 
for a positive clinical outcome as the tendon may already have sufficient levels of load-bearing 
aligned fibrillar structure. Future interventions may therefore need to focus on addressing load 
capacity in the surrounding aligned fibrillar structure, rather than normalizing tendon structure.
The total mCSA of the patellar tendons in our study is smaller (138.3 mm2) compared to previous 
reported mCSA of pathological tendons (154.9 mm2).16 Docking & Cook16 reported a relationship 
between the mCSA of disorganized tissue (echo-type III + IV) and total tendon mCSA. This may 
explain the difference in mean cross sectional area, because they reported a higher amount of 
disorganized structure compared to our study (median of 17.1mm2 compared to 10.9mm2 at 
baseline in our study).16 The difference in population of the studies may potentially have caused 
these differences; our study included an active sporting population with patellar tendinopathy, 
while the previous study was a clinical cohort.
Our study is one of the first studies presenting UTC characteristics of patellar tendinopathy 
patients. Only recently, the first results of UTC data in patellar tendons were presented.16,36 Different 
versions of the UTC (with a different ultrasound probe: SmartProbe 12L5-V or SmartProbe 10L5), 
populations and characteristics of the studies make it hard to compare absolute values. It is 
important to realize that these features may influence UTC results. Therefore, characteristics of 
UTC scans should always be reported in research as well as clinical practice.
This study contributes to the discussion on the relationship between clinical outcomes and 
tendon structure in patellar tendinopathy. However, many issues around this subject are still not 
elucidated. For a better understanding of patellar tendinopathy, studies on long term effects 
of treatments on tendon structure should be conducted. More research has to be conducted 
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in this field to be able to make grounded statements on this topic. The current study provides 
some rationale as to why positive clinical outcomes are possible with limited tissue regeneration. 
Future studies may also need to investigate other parameters (i.e. muscle strength and endurance, 
corticospinal changes) to explain potential positive clinical findings following load-based 
interventions.
Conclusion
A 4-week isometric or isotonic exercise program for patellar tendinopathy does not have an effect 
on tendon structure and dimensions quantified by UTC. Despite an improvement in patellar 
tendinopathy symptoms after the exercise program, tendon characteristics on UTC did not 
change accordingly within a 4-week timespan. This study supports that pain reduction does not 
necessarily mean a coinciding improvement in patellar tendon appearance.
Findings
Structural properties and dimensions of the patellar tendon on UTC do not change after a 4-week 
isometric or isotonic exercise program for athletes with patellar tendinopathy in-season, despite 
a decrease in symptoms.
Implications
Outcomes of treatments for patellar tendinopathy need to be based on clinical findings rather 
than imaging. More research is needed to determine the effect of treatments on tendon structure.
Caution
This study only reports short term effects of isometric and isotonic exercise on tendon structure. 
Effects of exercise programs of a longer duration and with longer follow-up periods need to be 
investigated.
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Objective: Injection treatments are increasingly used as treatment for patellar tendinopathy. 
The aim of this systematic review is to describe the different injection treatments, their 
rationales and the effectiveness of treating patellar tendinopathy.
Methods: A computerised search of the Medline, Embase, CINAHL and Web of Knowledge 
databases was conducted on 1 May 2010 to identify studies on injection treatments for 
patellar tendinopathy.
Results: Eleven articles on seven different injection treatments (dry needling, autologous 
blood, high volume, platelet-rich plasma (PRP), sclerosis, steroids, and aprotinin injections) 
were found: 4 randomised controlled trials, 1 non-randomised controlled trial, 4 prospective 
cohort studies and 2 retrospective cohort studies. All studies reported positive results. 
The Delphi scores of the four RCTs ranged from 5-8 out of 9. Different and sometimes 
contradictory rationales were used for the injection treatments.
Conclusion: All seven different injection treatments seem promising for treating patellar 
tendinopathy. Unlike the other injection treatments steroid treatment often shows a 
relapse of symptoms in the long term. Results should be interpreted with caution as the 
number of studies is low, few high-quality studies have been conducted and studies are 
hard to compare due to different methodology. More high-quality studies using the same 
cross-cultural reliable and valid outcome measure are needed, as well as further research 
into the pathophysiology. Finally, some implications are provided for clinicians who want to 
use injection treatments as part of their treatment for patellar tendinopathy, distinguishing 
between reactive and degenerative phase of patellar tendinopathy.
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Patellar tendinopathy or jumper’s knee is characterised by activity-related anterior knee pain 
associated with focal patellar tendon tenderness and intratendinous imaging changes.1 This injury 
is often found in both recreational and top level athletes.2 The prevalence is high especially in 
sports placing a high demand on speed and power for the leg extensors. Prevalence of patellar 
tendinopathy among elite volleyball and basketball players is 32 and 45%.2 As many as 53% of 
athletes with jumper’s knee even retire from their sport because of this injury.3
The current concept of jumper’s knee is that the underlying pathology is a degenerative 
tendinosis due to a failed healing response rather than a tendinitis.4–9 Although the exact aetiology, 
pathophysiology and healing mechanisms are not fully understood, it seems that cumulative 
microtraumata occur because of repetitive overload. The healing capacity of the tendon can be 
insufficient, and leads to a tendinosis zone.10,11 Another hypothesis is that inflammation plays a 
role in the early stage as well as in the chronic stage of tendinopathy.12 Recently it is suggested 
that patellar tendinopathy has a pathology continuum which starts with reactive tendinopathy 
(inflammation) and can progress to a degenerative tendinopathy with a potential of reversibility.13
Many different treatments are used for patellar tendinopathy, such as rest, anti-inflammatory 
medication, eccentric training, extracorporeal shockwave therapy (ESWT) and surgery. No single 
treatment has proven to result in a consistent, near-complete recovery in all patients.10,14,15 
The most common (usual care) intervention for patellar tendinopathy is eccentric exercise. Single-
leg decline squats are often used to increase patellar tendon forces.14,16,17 Performing an eccentric 
exercise program provides a 50-70% chance of improving knee function and pain, so that athletes 
can return to pre-injury levels of sports activity.18 However, in many patients an eccentric training 
program is not successful, therefore other methods of treatment have been developed, including 
(peri)tendinous injections. A certain volume of a liquid is injected into or close to the affected 
tendon to treat patellar tendinopathy. Many different injection methods, fluids and medication 
are currently used. To our knowledge, a comparison of the effectiveness of the various injection 
treatments does not exist. The aim of this systematic review is to describe the different injection 
treatments, their rationales and their effectiveness in treating patellar tendinopathy.
Methods
A computerised literature search of the Medline, Embase, CINAHL and Web of Knowledge 
databases was performed on 1 May 2010. The reviewers accomplished database searches with 
a combination of relevant search terms (Figure 1). Search terms on existing injection methods 
were phrased based on the expertise of sports medicine physicians of University Medical Center 
Groningen and by searching relevant literature. The search was limited to literature published in 
English. A total of 153 unique articles were found in the literature search.
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Only articles that met the following criteria were assessed:
1. Research population of humans with a diagnosis of patellar tendinopathy.
2. Research on the effectiveness of one type of injection treatment.
3. Clinical trials with pain, sport activity, patient satisfaction and/or physical tests as outcome 
measures.
Studies in patients with several different tendinopathies were only included if the results for 
patients with that condition were described separately. Titles and abstracts were examined 
independently by two reviewers to include those articles that met the aforementioned criteria. 
Twelve of the 153 studies met the criteria and were included after examining their title and 
abstract. The reference lists of the included articles were hand-searched to find other possibly 
relevant studies. No additional studies were found during this search. After reading the articles, 
one study was excluded in which multiple tendinopathies were investigated and no separate 
results provided for patellar tendinopathy. Hence the total number of studies included in this 
review is 11.
Two assessors independently assessed methodological quality of the included articles using 
Delphi criteria.19 The Delphi list is originally designed for the quality assessment of randomised 
controlled trials. In this review, the non-RCTs were also scored on this list to make some comparison 
possible. Although non-RCTs will not be able to obtain the maximum score as a result of the 
design of the Delphi list, in the comparison with RCTs this in fact will reflect the lower level of these 
studies. Although non randomised controlled trials can never obtain the maximum score as a result 
of the design; this is in fact a reflection of the lower level of these studies. To be able to compare 
the nonrandomised studies with each other, these were additionally scored for methodological 
quality on the Newcastle-Ottawa Scale (NOS).20 Although comments on this scale exists,21, Deeks 
et al.22 concluded that this scale is suitable for use in a systematic review. When the scores (Delphi 
and NOS) per assessor differed from each other, a consensus was reached in a meeting with both 
assessors.
Results
The eleven studies included comprised 4 randomised controlled trials, 1 non-randomised 
controlled trial, 4 prospective cohort studies and 2 retrospective cohort studies. Table I summarises 
the main features of these studies, with the injection treatment on which the most high quality 
research is performed listed first. Studies on seven different injection treatments were found in the 
literature search. These included 3 studies on PRP, 3 on steroids (1 in combination with aprotinin), 
2 on sclerosis, 2 on aprotinin (1 in combination with steroids), 1 high volume and 1 dry needling 
and autologous blood injection. No studies on heparin injections were found. The studies 
included patients with symptomatic patellar tendinopathy with a duration ranging from 1  to 
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database searching (n = 268)
additional records identied
through other sources (n = 0)
records after duplicates removed (n = 153)
records screened (n = 153)
records excluded – did
not meet inclusion
criteria (n = 141)
full-text articles assessed for
eligibility (n = 12)
full-text article excluded –
no separate results
(n = 1)
studies included in the
review (n = 11)
Steroids (n = 3)
PRP (n = 3)
Sclerosis (n = 2)
Dry needling & autologous 
blood (n = 1)
High volume (n = 1)
Search strategy in Medline, Web of Knowledge, CINAHL:
(patella OR patellar OR patellas) AND (tendinopathy OR tendinopathies OR tendinitis OR tendinitides OR 
tendonitis OR tendonitides OR tendinosis OR tendinoses OR jumper’s knee OR jumpers knee OR jumper knee) 
AND (injection OR injections OR injectable OR injectables OR platelet rich plasma OR PRP OR corticosteroid* 
OR glycosaminoglycans OR proteins OR dry needling OR autologous blood OR adrenal cortex hormones OR 
heparin OR sclerosis OR scleroses OR sclerosing)
Search strategy in Embase:
‘patella’/exp OR patellar OR patellas AND (‘tendinopathy’/exp OR tendinopathies OR ‘tendinitis’/exp OR 
tendinitides OR ‘tendonitis’/exp OR tendonitides OR ‘tendinosis’/exp OR tendinoses OR (jumpers AND ‘knee’/
exp) OR (jumper AND knee)) AND (‘injection’/exp OR ‘injections’/exp OR injectable OR injectables OR ‘platelet’/
exp AND rich AND ‘plasma’/exp OR prp OR corticosteroid* OR ‘glycosaminoglycans’/exp OR ‘proteins’/exp OR dry 
AND needling OR autologous AND ‘blood’/exp OR ‘adrenal’/exp AND cortex AND ‘hormones’/exp OR heparin/
exp OR ‘sclerosis’/exp OR scleroses OR sclerosing)
Figure 1. Literature search
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240 months. Furthermore, most studies included patients who had not improved from various 
other treatments. Age of the subjects ranged from 17 to 55 years and most subjects were athletes 
ranging from recreational to elite level. In most cases the Victorian Institute of Sport Assessment – 
Patellar questionnaire (VISA-P) or a pain level on a Visual Analogue Scale (VAS) was used as primary 
outcome measure. All studies reported positive effects of the investigated injection treatment. 
The two assessors who performed the quality assessment agreed on 95% of the items of the 
Delphi list and on 92% of the items of the NOS. A consensus was reached in a meeting with 
both assessors. The Delphi scores ranged from 1-8 on a 9-point scale, with the score of the four 
randomised controlled trials ranging from 5-8 points. The score of the 7 non-randomised studies 
on the NOS ranged from 2-6 on a 9-point scale.
Steroids
Most high quality studies investigated steroids; three randomised controlled trials, by Fredberg 
et al.,23 Kongsgaard et al.24 and Capasso et al.,25 were conducted on steroid injection treatments. 
The authors describe different reasons to include a steroid treatment group in their trial. Ultrasound 
images show that steroids can reduce inflammation and oedema of a tendon,34 but cannot 
repair degenerative changes. Although sparse histological documentation of inflammatory 
cells in damaged tendons exists, Fredberg et al.23 postulated that change in a tendon can be 
both degenerative and inflammatory, and a significant reduction in oedema and thickness of 
the steroid-treated tendons can probably be achieved through an influence on inflammatory 
processes. According to Kongsgaard et al.,24 effects of steroid injections on patellar tendinopathy 
remain elusive. Some studies indicate harmful effects while others found reduced tendon pain, 
swelling and vascularisation. For this reason, Kongsgaard et al.24 included a steroid group in their 
research. A steroid group is also included in a study by Capasso et al.25 because steroids are often 
used in the management of both tendonitis and degenerative joint disease.
Fredberg et al.23 concluded that a steroid treatment can normalise the ultrasonographic 
pathological lesions in patellar tendons and has dramatic clinical effects. The often-seen relapse of 
symptoms in patients is ascribed to the combination of steroids with too aggressive rehabilitation. 
A limitation of the study is the short cross-over period, which allows placebo and treatment 
groups to only be compared in the short term, while it is long-term effects that have particular 
clinical relevance.
The study of Kongsgaard et al.24 evaluated clinical, structural and functional effects of 
steroid injections, eccentric training and heavy slow resistance training in patellar tendinopathy. 
They suggest that the investigated treatments had similar (positive) short-term effects; however 
on a long-term basis the eccentric and resistance group maintained their effects, while the effects 
of steroids deteriorated at 6 months follow-up.
The aim of Capasso et al.25 was to investigate the efficacy and tolerability of aprotinin injections. 
The results of steroid treatment were significantly worse than aprotinin treatment. One of the 
limitations of this study is the outcome measure. A clinical assessment of symptoms and sport 
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resumption classified as poor, fair, good or excellent as outcome measure has its limitations, and 
it is questionable whether this is a sensible and reliable outcome measure.35 Furthermore, the lack 
of a baseline measurement is another limitation of the study.
It is remarkable that all outcome measures in the steroid injection studies of Kongsgaard et al.24 
and Capasso et al.25 showed improvement in the short term, yet improvement deteriorated in 
the long term (6 months). A relapse was also observed by Fredberg et al.23 from the 4-week to 
6-month follow-up. Further, the final follow-up measurements of the studies of Kongsgaard et al.24 
and Capasso et al.25 showed better outcomes of respectively training protocols and aprotinin 
injection than of steroid injection.
Sclerosis
The effects of sclerosing injections on patellar tendinopathy patients are investigated by 
two studies by Alfredson et al.27 and Hoksrud et al.26. Sclerosis is the injection of a chemical irritant 
(e.g. polidocanol). A link between neoneurovascularisation and tendon pain in patients with 
chronic patellar tendinopathy is assumed from previous research.36 Neovessels and accompanying 
nerves might be responsible for the pain symptoms; treatment with sclerosing injections targets 
the neovessels. It is hypothesised that by destroying the neovessels and accompanying nerves 
chemically, the tendon pain could be cured.
Alfredson et al.27 found a significant decrease in pain during activity, concluding that sclerosis 
has a potential for curing tendon pain. The limitation of a lack of control group exists in this study. 
A strong trend towards a group-by-time interaction in VISA-P score after 4 months (p = 0.52) was 
found by Hoksrud et al.26 A significant improvement in VISA-P score (p = 0.01) was reported for the 
treatment group, whereas no change was reported for the control group (p = 0.86). A limitation 
of this study is the relatively short follow-up of the placebo group, yet the data of the control 
group indicates that no effect was present in the placebo period and dramatic improvement was 
observed when the control group was offered sclerosis treatment (cross-over after 4 months). It is 
concluded that the observed changes can be attributed to the sclerosing injections, therefore 
sclerosis seems to be a promising treatment.
Aprotinin
Aprotinin injection treatment was investigated by Capasso et al.25 and Orchard et al.28 The rationale 
of aprotinin treatment is based on many recent publications that found an increase in matrix 
metalloproteinases (MMPs) in tendinopathic tissue. Excessive collagenases may be a reason 
for delayed recovery in patients.37 With this presumption Orchard et al28 and Capasso et al.25 
hypothesised that local injection of a collagenase inhibitor seems sensible for treating chronic 
tendinopathy. Aprotinin is such a collagenase inhibitor; in vitro it is a strong inhibitor of MMPs, 
including the collagenases, with a likely mechanism of inhibition of the plasmin-activation 
pathway of MMPs.28
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Fredberg et al.,23 2004 1: 2-3x USG 3.5 mL of 10 mg/
mL lidocaine & 0.5 mL kenalog 
containing 20 mg triamcinolone 
to paratenon as near damaged 
area as possible, one injection 
longitudinally to both sides
2: placebo: 3.5 mL of 1% lidocaine 
and 0.5 mL 20% intralipid (cross-






















All improved, esp. short 
term. Pressure pain only 
signif. impr. after 3 wk 
(p=0.02).
Walking pain 2.9, 1.7,(1 
wk) 1.3 (4 wk), 2.4 (6 mo) 
signif. diff. (p=0.02) with 
placebo (=4 wk). Blazina 
stages better after 3 mo 










Kongsgaard et al.,24 2009 1: 2x USG 1 mL of 40 mg/
mL methylprednisol in 0.5 
mL of lidocaine injection to 
peritendinous tissue posterior to 
hypoechoic area.
2: eccentric training.



















12 wk (end 
interv.), 6 
mo







Baseline VISA-P 1. 64, 2. 
53, 3. 56
12 wk VISA-P 1. 82, 2. 75, 
3. 78
½ yr VISA-P 1. 64, 2. 76, 3. 86
3 seems best, see article for 
other outcome measures.
After 12 wk all signif.






2 + 3: good 
short- & long-term 
(especially 3)
5 / NA
Capasso et al.,25 1997 1: 62500 units aprotinin & 2.5 mL 
of 1% lignocaine.
2: 40 mg methylprednisolone 
acetate & 2.5 mL of 1% lignocaine 
injection.
3: 5 mL of 0.9% NaCl.
Paratenon (in bursa or near 
tendinous insertion)




















1, 12 mo Poor, fair, good 
or excellent 
(symptoms + sport 
resumption)
1: 72% good/exc, 7% poor,
2: 59% good/exc, 12% poor,
3: 28% good/exc, 25% 
poor.
Signif. diff. groups:
1 better than 2,3 &







Hoksrud et al.,26 2006 1: sclerosis max 6x USG max. 2 mL 
per knee, 10 mg/mL polidocanol 
injection to paratenon in
neovasc. area until all vessels 
closed
2: placebo = lidocaine with 
adrenalin
(4 mo cross-over) max 3 sclerosing 
injections




41 ± 37 (4-240) mo
CG:
24.3 (17-35) yr
33 ± 43 (6-180) mo
Elite athletes
? 2nd wk light 
sport-specific 
training. 








12mo f.u.: 77 (p<0.001)
VAS ± 8 after 12 mo.
Signif. impr. sclerosis vs. no 
signif. diff. CG (4 mo).
Signif. impr. in 





Alfredson & Ohberg,27 2005 Sclerosis 1 -5 x mean 3
USG 1-2 ml 5 mg/ml polidocanol 
injection to paratenon in neovasc. 





















6 mo Neovasc. stage, VAS 
pain during activity
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Orchard et al.,28 2008 No USG 3 mL Trasylol with 
30,000 KIU (4.2 mg) aprotinin 
combined with 2 mL lignocaine 
2% (local anaesthetic) injection, 
















of treatment, from 
completely cured to 
much worse
7% completely cured, 34% 
much btr, 31% slightly btr, 
28% similar, 3% slightly 
worse
Treatment cured? Sure btr 
31%, think btr 34 %, unsure 
34%






Volpi et al.,29 2007 1x USG (3 mL) PRP (anticoagulant 
1:10, 50-150mL NaHCO3 solution 
(for pH)) intratendon injection 





















Start full sport 
>12 wk
17 wk















Kon et al.,30 2009
 
3x non-USG (5 mL) PRP (± 6.8 mill 
platelets) intratendon injection 
























Tegner, EQ-VAS & SF 










Filardo et al.,31 2009 1: 3x non-USG (5mL) PRP (± 
6.8 mill platelets) intratendon 




























Tegner, EQ-VAS, pain 
level, complications, 
functional 
recovery & patient 
satisfaction 
Baseline EQ-VAS: 52.7
f.u. (EoT): 68.0, f.u. (6 mo): 
78.3
Baseline Pain level: 6.6 f.u. 
EoT: 4.3, f.u. 6mo: 3.1
Baseline Tegner: 3.7 6 
mo: 6.6
Only Tegner signif. diff. 
between TG and CG 
(p=0.048)
Encouraging, 





2 / 6 
James et al.,32 2007 2x USG 3 mL autologous blood 
injection to intratendon proximal 
to area of interstitial tears





















US: 22x reduced thickness 
& focal alteration.
Still neovasc. 23x, 9 same, 5 








Crisp et al.,33 2008 (high volume) 1x USG 10 ml 
bupivacaine 0.5%, 25 mg 
hydrocortisone & 12-40 ml normal 
saline injection at interface 
between tendon & Hoffa’s body 




9/9 29.2 (18-45) yr
> 3 mo,















Baseline VAS pain: 87
2 wk 31 (p=0.018).
Baseline VAS function: 94
2 wk 36 (2 wk) (p=0.018).




btr = better; CG = control group; conserve = conservative; diff. = different; EoT = end of therapy; exc = excellent;  
f.u. = follow-up; impr. = improvement; incl. = including; mo = months; NA = not applicable; neovasc. = neovascularisation;  
NR = non-randomised; prosp. = prospective; RCT = randomised controlled trial; retr. = retrospective; TG = training group;  
US = ultrasound; USG = ultrasound-guided; wk = weeks, yr = years.
Table I. (Continued)
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btr = better; CG = control group; conserve = conservative; diff. = different; EoT = end of therapy; exc = excellent;  
f.u. = follow-up; impr. = improvement; incl. = including; mo = months; NA = not applicable; neovasc. = neovascularisation;  
NR = non-randomised; prosp. = prospective; RCT = randomised controlled trial; retr. = retrospective; TG = training group;  
US = ultrasound; USG = ultrasound-guided; wk = weeks, yr = years.
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The study of Capasso et al.25, briefly described in the steroids paragraph, suggests that aprotinin 
injections may have a lasting beneficial effect for patellar tendinopathy patients. Orchard et al.28 
conducted a retrospective cohort study, investigating whether aprotinin injection treatments for 
common forms of tendinopathy would lead to good clinical improvement. They concluded that 
for major load-bearing tendons (e.g. Achilles, patella, hamstring tendons) in active individuals, 
aprotinin is a more appropriate second-line injection option than cortisone preparations. 
Limitations of this study are the lack of a control group and its retrospective design, and the 
outcome measures only comprise patients’ opinions about their condition. Only two low-quality 
studies investigating aprotinin exist. Although results look promising, it is hard to draw conclusions 
from these studies.
Platelet-rich plasma
Three studies investigated the effects of platelet-rich plasma (PRP) injection treatments for patellar 
tendinopathy: Volpi et al.,29 Kon et al.30 and Filardo et al.31. PRP is prepared from autologous blood, 
it contains a ‘cocktail’ of growth factors, which is coupled with a further release of these factors 
when the platelets are activated. Growth factor application has an important role in the healing 
of damaged tissue. This offers opportunities in aiding regeneration of tissue with low healing 
potential like in patellar tendinopathy. A complex regulation of several growth factors increases the 
expression of procollagen types I and III, improves mechanical properties, and promotes tendon 
cell proliferation and tendon healing.30 The exact working mechanism of this complex process is 
not fully understood. The precise role of the ‘cocktail’ of growth factors is not clear, although it 
seems that among other growth factors PDGF, TGF- ß and VEGF promote tissue healing.38–41
All studies concluded that PRP injection is a promising treatment. However, the quality of these 
studies is low (Delphi score = 2). Among the limitations are the absence of a control group and the 
use of a control group with different population characteristics than the treatment group.
Dry needling and autologous blood
Dry needling and autologous blood injections are only investigated in a combination in one study 
by James et al.32 Dry needling is repeatedly passing a needle through the abnormality of a tendon, 
and is applied to stimulate an inflammatory response within the tendon. James et al.32 hypothesise 
that the collagen fibres in the tendinosis area are disrupted, stimulating an internal bleeding. 
Strengthening of the tendon should then be accomplished by the formation of granulation 
tissue which is a consequence of the inflammatory response. Their rationale for autologous blood 
injection closely resembles the previously described rationale for PRP; autologous preparations 
rich in growth factors induce cell proliferation and promote synthesis of angiogenic factors 
during the healing process. Several growth factors (e.g. PDGF and TGF-ß) may also act as humoral 
mediators in the induction of the healing cascade. For these reasons they investigated dry 
needling in combination with autologous blood injection.
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The aim of James et al.32 was to assess the efficacy of ultrasound-guided dry needling and 
injection of autologous blood as a treatment for patellar tendinopathy. They concluded that this 
combination is a promising treatment for the condition. A limitation is the absence of a control 
group. The combination of therapies and low quality of this study furthermore complicate a 
statement about a single method of treatment.
High volume
High-volume injection treatment is investigated in one study by Crisp et al.33 The rationale used 
in this study is similar to that used for sclerosing injection treatment by Alfredson et al.27 and 
Hoksrud et al.26 The hypothesis of Crisp et al.33 was that disruption of neoneurovascularisation 
could be achieved by mechanical means, namely by injecting large volumes of fluid in the area 
where the neovessels penetrate the tendinopathic lesion (interface between the posterior aspect 
of the paratenon of the patellar tendon and Hoffa’s body). Power Doppler ultrasound showed 
the immediate disappearance of neoneurovascularisation after injection.33 They additionally used 
small amounts of local anaesthetic and corticosteroids to relieve immediate pain and prevent an 
inflammatory reaction, respectively. Their aim was to evaluate a high-volume injection treatment 
for patellar tendinopathy. They found a significant improvement in VISA-P after a high-volume 
injection treatment and concluded that high-volume injections are helpful for the treatment of 
patellar tendinopathy. Because only one low-quality study on this treatment exists, it is hard to 
make definitive statements on the treatment. The main limitation of this study is its retrospective 
design, which may result in a recall bias as the VISA-P had to be completed in a retrospective 
manner. Furthermore, the small amount of corticosteroids that was added to prevent an injection-
related inflammatory response may be a confounding factor.
Discussion
This is the first systematic review to provide a complete review of the existing literature on 
injection treatments for patellar tendinopathy. Eleven studies on 7 different injection treatments 
were found, overall reporting positive outcomes. However, a careful interpretation of the results 
is necessary, as the number of studies is low and few high-quality studies are available. The mean 
Delphi score is only 3.4 (range 1–8) out of a maximum of 9.
The only injection treatment on which three randomised controlled trials were conducted 
is steroids. These studies indicate that steroid treatment is effective in the short term, yet show 
relapse in the long term. The results of a systematic review by Barr et al.42 on the effectiveness of 
steroid injections compared with physiotherapeutic interventions for lateral epicondylitis show the 
same: while steroid treatments were favourable in the short term compared to physiotherapeutic 
interventions, the latter were more favourable on the intermediate-to-long term.42 Other reviews 
on steroid treatment for shoulder and elbow tendinopathy show relapse after steroid injections 
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as well.43,44 A recurrence rate of 72% after steroid injections in lateral epicondylitis is reported.45 
Additionally , an impaired synthesis of collagen has been found in tendons injected with 
steroids.24 It can therefore cautiously be concluded that steroids have a positive effect on patellar 
tendinopathy in the short term, but a relapse of the symptoms occurs in the long term.
As for the other injection treatments, all studies report positive outcomes. It might thus be 
possible that an intra- or peritendinous injection by itself already influences the symptoms of 
patellar tendinopathy positively. One of the insights on injection therapies is that any injection 
with an irritant solution can be beneficial for the treatment of a condition.46 A review on this 
so-called prolotherapy showed positive results of treatments groups compared with controls, 
although limited high-quality studies on prolotherapy for musculoskeletal pain or sport-related 
soft tissue injuries exist.46 Another possible explanation for the positive outcomes in all studies 
is the existence of a publication bias; also the low quality designs have to be taken into account.
The limited number of studies makes it hard to draw firm conclusions on the effectiveness 
of the individual injection therapies. Only one of the studies included in this review compared 
multiple injection treatments, and found that aprotinin injections result in more improvement 
in patellar tendinopathy patients than steroid injections.25 However, the quality of this study is 
moderate and no other studies exist confirming these results. Further, there are only 4 randomised 
controlled trials and 1 non-randomised controlled trial comparing injection treatment with a 
control group receiving training, no treatment or lidocaine injection. Because of differences in 
concurrent treatments, outcome measures, injection protocols and study populations, the studies 
are difficult to compare and no firm statements on the differences in effectiveness of the injection 
treatments can be made.
Another treatment besides injection is thought to be required to promote healing of a 
tendinopathic tendon, as the healing process is a complex system in which mechanical and 
chemical factors work together.47,48 A combination of an injection together with a mechanical 
stimulus (physical therapy) does raise the question where the possible effects can be ascribed to, 
injection or physical therapy. No studies exist in which injection therapy together with physical 
therapy is compared to physical therapy alone. However, in most studies described in this review, 
the symptoms did not improve from a previously performed exercise program. Therefore, an 
injection in combination with physical therapy seems beneficial and might be of greater benefit 
than solely an exercise program. Although some form of physical therapy program was prescribed 
in all the studies, large differences exist between studies in type of concurrent treatments, which 
hinders comparisons. For example, in some studies patients were allowed to resume their 
sport activities the second week after injection, while in other studies patients were allowed to 
resume their sport activities after 12 weeks. Moreover, a combination of injection treatment with 
physical therapy results in inconclusiveness as to which treatment the effects can be ascribed to. 
Concurrent treatment, tendon loading in combination with an injection, does however seem to 
be needed for treatment effectiveness. In order to be able to compare the results, it is advised to 
standardise the concurrent treatment and report it clearly.
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Another factor that makes it difficult to compare the studies is that no universal outcome 
measure is used. The most used outcome measure is the VISA-P, but several VAS scores, degree of 
satisfaction and the Tegner scale are also used. It is important to have the same reliable and valid 
outcome measure to compare studies; the need for internationally accepted golden standards 
in outcome measures is also described by Frohm et al.49 The most suitable outcome measure 
for studies investigating outcome of treatments in patellar tendinopathy is possibly the VISA-P 
score, because it is a reliable index of the severity of patellar tendinopathy and it is specifically 
designed for that condition.50 This outcome measure is already used often in studies on patellar 
tendinopathy. Besides English, the VISA-P is also proven to be reliable and valid in Swedish,49 Italian51 
and Dutch.52 The VISA-P score may provide a suitable outcome measure in these languages, but 
cross-cultural validation of the VISA-P for other languages has yet to be examined.
The studies also differed on the characteristics of the study population. One example is whether 
patients received previous therapy and which type. Patients in six studies were recalcitrant to 
previous treatments, 1 study had a ‘mixed’ population (91 had no previous therapy and 25 steroid 
treatment) and in 4 studies the previous therapy of the treated patients was not mentioned.24,26,28,32 
Although the mean duration of symptoms was longer than 12 months in all studies, the range 
was wide (1-240 months). The fact that the effectiveness of injection treatments is determined in 
different patient groups complicates comparison of treatments.
No severe adverse events related to the injections were reported in the subjects of the 
reviewed studies. The worldwide distribution of aprotinin (Trasylol®) is currently suspended by 
the distributor because of health risks when injected intravenously in high doses during cardiac 
surgery. In tendinopathy, an anaphylactic reaction is reported as a possible side effect of an 
aprotinin injection. An allergic reaction is rare after initial aprotinin injection (1 per 1000 reported 
in anaesthetics), however not uncommon in following injections (up to 3% per injection) for 
chronic tendinopathies.53 Orchard et al.28 reported 13 probable systemic allergic reactions, but 
these were managed by a single adrenaline injection. A sclerosing injection with polidocanol has 
a possible risk of tendon necrosis due to disturbed tendon blood flow, however this risk is only 
small and much higher in for example surgery.26,27 Furthermore, a small chance of rupture of the 
tendon exists after every injection in or near a tendon. The steroid injection is the only injection 
treatment of which some evidence exists that it weakens the tendon and seems to increase the 
risk of rupture.54,55 Finally, a negligible chance of infection exists after every injection.
It can be concluded that more high quality clinical studies are needed. The fact that the precise 
working mechanism of the injection treatments is not fully known also needs more research. 
Moreover, issues related to this, like the place of the injection need more clarification. Seven of 
the reviewed studies used peritendinous and four used intratendinous injections. The studies on 
autologous blood and PRP injections all used intratendinous injections and the studies on all other 
injection treatments used peritendinous injections. It is demonstrated that intratendinous steroid 
injections can temporarily weaken the tendon in contrast to peritendinous steroid injections.54 
Peritendinous steroid injections are therefore preferred. Further research is needed to obtain a 
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better understanding of the effects of intra- versus peritendinous injections in other injection 
treatments.
In line with the previous, further clarification of the pathophysiology is needed to better 
understand the different and sometimes contradictory rationales that are described. These 
rationales vary from stimulation of the healing process to inflammatory stimulation or suppression 
and neovessel destruction. Most research indicates that hardly any inflammation is involved 
in chronic patellar tendinopathy, it is thought to be a failed healing response. However, some 
researchers recently postulated that inflammatory cells are involved in chronic patellar tendinopathy 
and it actually may be a combination of a degenerative and inflammatory condition.12, 56 Cook 
et  al.13 advocate a model in which the pathology of a tendinopathy proceeds through several 
stages. They divided the pathology of patellar tendinopathy for clinical use into two stages: 
reactive/early tendon disrepair and degenerative/late tendon disrepair. Based on this model, 
biological reasoning and the current knowledge, some cautious recommendations can be given 
for clinical practice. In the reactive/early tendon disrepair phase, treatment should consist of load 
reduction, pain management (NSAIDs) and, if one wants to give injection treatment in this phase, 
steroid injections. The other described injection treatments can be given in the degenerative/late 
tendon disrepair phase, as part of an exercise based training program including slightly painful 
eccentric exercises, to improve tendon regeneration. However, more research is needed to gain 
better insight into the pathophysiology and consequently the best injection treatment each stage 
of patellar tendinopathy.
Conclusion
Overall, injection treatments seem promising for the treatment of patellar tendinopathy, however 
present research is mainly of low quality and confers no clear benefit to a given intervention. Steroid 
injection treatment is effective in the short term, but shows relapse into pre-treatment levels in 
the long term. It is hard to draw firm conclusions on the effectiveness of injection treatments, as 
the number of studies is low and only few high-quality studies are available. The rationales of 
the several injection treatments differ, yet some seemingly contradictory rationales could have 
a place when considering the continuum model of tendon pathology. More high-quality clinical 
research and more research into the condition’s pathophysiology is needed to determine whether 
injection treatments are effective and in which particular stage of patellar tendinopathy.
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What is already known about this topic
Patellar tendinopathy is a hard-to-treat injury with a high prevalence especially in jumping 
athletes. Injection treatments are increasingly used as treatment for patellar tendinopathy. 
The amount of research on injection treatments is growing
What this study adds
This is the first systematic review into injection treatments for patellar tendinopathy. 
The presumed working mechanisms of the injections and outcomes of the studies are 
presented. Overall, injection treatments seem promising, however results need to be 
interpreted with care, as the number and quality of the studies are limited.
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Objectives: To describe a post platelet-rich plasma (PRP) injection, exercise-based physical 
therapy program, investigate feasibility and report the first results of patellar tendinopathy 
patients treated with PRP injection combined with the physical therapy program.
Study Design: Case series.
Setting: A PRP injection followed by a physical therapy program seems promising for the 
treatment of patellar tendinopathy. However, descriptions of physical therapy programs 
are often limited and incomplete.
Participants: Five patellar tendinopathy patients (six tendons) in the degenerative phase.
Main outcome measure: VISA-P score.
Results: Muscle strength, endurance, power and retraining sport-specific function form 
the basis for the physical therapy program aiming to improve the load capacity of the 
knee. The program is characterised by gradually increasing intensity and difficulty of 
exercises. Five of the six tendons showed an improvement of at least 30 points on the 
VISA-P after 26 weeks.
Conclusions: This study extensively describes, based on current knowledge, a physical 
therapy program after PRP injection for patellar tendinopathy patients. The combination 
treatment reported in this study is feasible and seems to be promising for patients in the 
late/degenerative phase of patellar tendinopathy.
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Patellar tendinopathy is a common injury among athletes who place a high load on the extensor 
mechanism of the knee.1,2 It is often seen in ‘jump sports’ like volleyball and basketball.1 Patellar 
tendinopathy, also known as jumper’s knee, is characterised by pain and tenderness most 
commonly at the proximal end of the patellar tendon.3 This injury can have a major impact on 
an athlete’s career/sporting life because of its chronic character.4 The results of treatments for 
patellar tendinopathy are variable. First-line usual care is based on load adjustment and eccentric 
training.5–9 A wide range of treatments like anti-inflammatory medication, extracorporeal 
shockwave therapy, injection treatments and surgery are often tried subsequently. However, no 
consensus exists on the treatment to be implemented, as results are often disappointing.9,10 The 
variable results might be explained by the phase of patellar tendinopathy in which the patient is 
treated. A distinction in treatment might be necessary between the reactive tendinopathy/early 
tendon disrepair and the degenerative/late tendon disrepair phase of a tendinopathy.11 This study 
focuses on the degenerative/late tendon disrepair phase of patellar tendinopathy.
The healing of a tendinopathic patellar tendon is a complex system in which mechanical and 
biological factors work together.8,12 A combination of treatment strategies therefore seems to be 
required to heal a tendinopathic tendon. One promising although not yet extensively investigated13 
injection treatment for a tendon in the degenerative/late tendon disrepair phase is injection with 
platelet-rich plasma (PRP). The literature states that the presumed working mechanism is not solely 
the injection of PRP (‘cocktail’ of growth factors) in or near the patellar tendon, but the co-action of 
chemical and mechanical factors.14,15
A study from Virchenko et al.16 on the interplay of injection of platelets and mechanical 
stimulation on rat tendons showed that both biological and mechanical stimulation is needed 
to optimise healing of a tendon. They concluded that only the early phases of regeneration 
are influenced by platelets; this stresses the importance of development through mechanical 
stimulation early on in the process of healing. The necessity to combine a PRP injection with 
physical therapy is also emphasised by Kon et al.,17 who performed a pilot study on PRP injections 
for the treatment of patellar tendinopathy. The participants who did not follow the rehabilitation 
program achieved poorer results at follow-up. Overall, the literature indicates that to optimise 
treatment PRP injection should be combined with mechanical stimulus of the tendon.
Although all the available studies on different injection treatments state the importance of 
mechanical loading through a physical therapy program, the description of such program is 
often limited and incomplete.18 Furthermore, large differences exist between the physical therapy 
programs, and the content of the most effective program is not clear.18 Since a physical therapy 
program plays a major role in the outcome of the treatment, a well-described program with a 
clear rationale is essential to guide the physical therapist and to compare treatments19. The aim of 
this study is therefore to describe a post-PRP injection, exercise-based physical therapy program 
based on current literature insights and expert opinion, investigate feasibility and report on the 
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This prospective case-series study reported the first results of a combination treatment of PRP 
injection followed by a well-described physical therapy program. In order to gain insight into the 
outcome of the combined treatment, outcome measures were assessed before the treatment 
(baseline) and 6 weeks, 12 weeks, 16 weeks and 26 weeks after injection. Patients also had to fill in 
a web-based diary every week. The injection and all the tests and physical therapy sessions took 
place at the Center for Sports Medicine of University Medical Center Groningen, The Netherlands. 
Patients were included during the period March–November 2010.
Participants
The participants were all patients of the Sports Medical Center of University Medical Center 
Groningen. They were diagnosed with patellar tendinopathy by one single sports medicine 
physician (JZ). Inclusion and exclusion criteria are described in Table 1. All patients gave their 
informed consent for participation in the study.
Table 1. Inclusion and exclusion criteria
Inclusion criteria
• History of knee pain in the proximal section of the patellar tendon or its patellar insertion in connection 
with training and competition
• Symptoms for over 12 months (current symptoms for at least three months)
• Age 18-40 
• Palpation tenderness of the corresponding painful area
• VISA-P score < 80
• Ultrasound characteristics of a tendon in the degenerative phase (hypoechoic zones)11 
• Recalcitrant to previous conservative treatment (at least 12 weeks eccentric training)
Exclusion criteria
• Acute knee or patellar tendon injuries
• Chronic joint diseases
• Signs or symptoms of other coexisting knee pathology
• Pregnancy
• Bleeding disorders and haematological diseases
• Malignancy
• Knee surgery
• Injection of any kind in the patellar tendon in the preceding three months
• Use of NSAIDs in the last 5 days before or first 6 weeks after injection or daily use of drugs with a putative 
effect on patellar tendinopathy in the last year (e.g. nonsteroid anti-inflammatory drugs, fluorchinolones)
• Current use of anticoagulants
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Patients received an ultrasound-guided PRP injection in the degenerative zone of the 
patellar tendon. PRP was prepared using a 15 ml ACP double syringe (Arthrex Nederland B.V., 
The  Netherlands). For the preparation of PRP, 10 ml venous blood was withdrawn from the patient. 
The blood was centrifuged for 5 minutes at 3500 RPM. The PRP was injected under ultrasound 
guidance into the hypoechoic area of the tendon using a 22-gauge needle. One single physician 
performed the injections (JZ). The patient had to wear a temporary splint for the first 48 hours 
after injection. Platelet counts of the PRP were performed after injection in a laboratory of the 
University Medical Center Groningen. The PRP injections contained a relatively low concentration 
of platelets (433 x 109/l, 95%CI (256-609)).
Physical therapy program
The physical therapy program was designed based on current insights from the literature and 
expertise of a physical therapist, a sports medicine physician and human movement scientists. 
Muscle strength, endurance, power and retraining sport-specific function form the basis for the 
physical therapy program aimed at improving the load capacity of the knee. The program is 
characterised by gradually increasing intensity and difficulty of exercises. Before increasing load, 
execution of exercises should be correct and controlled, and pain should not exceed a score 
of 50 on the Visual Analogue Scale (VAS) (0-100). The load can be increased relatively quickly 
when exercises are executed properly, to ensure a quick return to sports. The program consists 
of five phases. The aim of the first three phases is to create conditions for an optimal recovery. 
The final two phases target the sport-specific load of a patient. The duration of each phase is a 
time indication and individually dependent on the progression of the patient. A description of the 
physical therapy program is provided in Figure 1. Besides an explanation of the program from the 
physical therapist, the patients received a printed version of the program and an explanation of 
the exercises on DVD. This DVD was created to ensure a correct (qualitatively good) execution of 
the exercises and to increase patient compliance.20 All exercises of the physical therapy program 
were explained and displayed using video clips.
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Phase 1 – Inflammation/proliferation phase (0-2 weeks)
Inform and advise patient, rest, low load (1x week physical therapy)
Day 1-3 Inform and advise patient
• Rest.
• Low load (walk with two crutches).
• Reduce pain (cryotherapy).
Day 4-7 Inform and advise patient
• Optimise ROM, if necessary combined with isometric exercises for m. Quadriceps.
• Increase ADL with VAS pain score < 50.
Day 7-14 Exercise
• Optimise knee flexion and extension combined with unloaded cycling (hometrainer).
• Walking: 100% load without crutches.
• Home exercise program: m. Quadriceps isometric contraction, active straight-leg raise, abduction side-lying 
(2x day, 3 x 20 reps., rest interval 30–60 sec.).
Pain score must not exceed 50 on the VAS scale during all exercises and activities of daily living. 
Phase 2 – Proliferation phase (weeks 2-4)
More dynamic and active exercises (1x 2 weeks physical therapy)
• Higher cycling intensity (build up load), goal: 20-30 minutes.
• Home exercise program:
– Squats, calf extensions, single-leg squat with arm swing, abduction side-lying. Cycling on home trainer 
(3 x 20 reps. rest interval 30-60 sec.).
– Exercises have to be possible (need to be executed) in complete ROM.
– Closed chain exercises, mainly coordination and strength endurance. Stability plays no major role yet.
– Light pain (VAS < 50) allowed during exercises, however the pain must decrease after the exercise. 
Phase 3 – Remodelling phase (weeks 5, 6)
Active exercises are expanded (2x week physical therapy)
• Eccentric exercises are integrated into the program.
Home exercise program (on days without supervised physical therapy): 2 days/week single-leg squat on 
decline board (25°).
• Various exercises (strength endurance) to increase load capacity of lower extremity, including hometrainer 
warm-up, core stability exercises, lunges, abduction side-lying, squats and step-downs (3x15 reps., rest 
interval 30 sec.).
• Integrate core stability exercises (e.g. prone bridge, side bridge).
A pain increase within 48 hours is allowed (VAS < 50), but the pain must have disappeared after 48 hours. No leg 
extension in open chain.
Phase 4 – Integration phase (weeks 7, 8)
Exercises progressing to higher %1RM, 3 x 8-15 reps., rest interval 30 sec., more muscular hypertrophy (2x week 
physical therapy)
• Daily eccentric training (2x day, 3 x 20 reps.).
• Run-and-Walk exercises of increasing intensity and difficulty (starting with interval walking/jogging, 
advancing to multidirectional, acceleration and deceleration running).
• Jump exercises with increasing difficulty. (Correct execution with controlled landing important. Start with 
height jumps, progress to long jumps.)
• Core stability with higher difficulty.
• Sport-specific exercises at maximal and speed strength.
Phase 5 – Sport-specific phase (After 8th week)
• Daily eccentric training continues (2x day, 3x20 reps.) until end of supervised physical therapy program 
(± 12 weeks).
• Advance to more sport-specific exercises, e.g. plyometric, a-lactic, multidirectional running, acceleration 
and deceleration. 
ADL = Activities of Daily Living; reps. = repetitions; ROM = Range Of Motion; sec. = seconds; VAS = Visual Analogue Scale
Figure 1. Physical therapy program
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Primary outcome measure was the VISA-P score, rated using a self-reported questionnaire and 
found to be reliable and valid to measure the severity of patellar tendinopathy.21 The score ranges 
from 0 to 100. A score of 100 indicates the maximum score for an asymptomatic athlete.
Secondary outcome measures were pain ratings on a VAS during Activities of Daily Living (ADL) 
and functional tests: 1x single-leg decline squat (SLDS), 10x SLDS, maximal jump test and triple-
hop test.22 The SLDS is a squat performed on one leg to 60˚ of knee flexion on a 25˚ decline board. 
The maximal jumping test entails three countermovement jumps performed on the injured leg 
of the patient. The triple-hop test consists of three consecutive jumps; patients are instructed 
to jump as far as possible in three jumps on the injured leg while maintaining balance on one 
leg for at least 2 seconds after every jump. The tests were assessed by a specially trained human 
movement scientist. Patients were also asked if they had experienced improvement and if they 
would recommend this treatment to a friend or relative. Furthermore, patients were asked to fill in 
a web-based diary every week. They were asked for pain, degree of compliance with the program, 
complications, side effects, other treatments, other activities and medication used.
Degree of compliance with the program was determined with the question ‘To what extent 
did you comply with the exercise program? (0-10)’. The mean self-reported compliance with the 
program was determined by calculating the mean score on this question for all weeks. Descriptive 




Subject characteristics per case are presented in table 2. Two men and three women participated; 
mean age was 27 years. One of the patients had bilateral complaints and received the treatment 
for both knees with an interval of two weeks between treatments (case numbers 1a and 1b). 
The  patients had a mean duration of symptoms of 38.4 months. Previous treatments of the 
patients included rest, eccentric training, extracorporeal shockwave therapy and deep friction of 
the tendon. All patients were recreational athletes.
Compliance and side effects
Table 2 also shows patients’ self-reported compliance with the program. The patients stated in 
the diary that they never performed exercises more often than prescribed in the program. They 
did not comply fully with the program; reasons for non-compliance were no time, no motivation, 
holidays or other injuries.
None of the patients consulted other medics/paramedics or physicians for their patellar 
tendinopathy during the course of this study. One of the patients (case number 5) underwent 
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Figure 2. VISA-P scores per case
a foot operation in the treated leg 18 weeks after injection, which influenced his activities in the 
following weeks (i.e. the participant performed fewer physical activities). This could have caused 
the drop in VISA-P score between weeks 16 and 26. Patients did not report any complications or 
side effects during and after the treatment. No problems were reported by the sports medicine 
physician and the physical therapist during the treatment either.
Clinical assessment measures
Table 2 and figure 2 show the primary outcome measure (VISA-P) per case. Five of the six tendons 
show an improvement of at least 30 points on the VISA-P after 26 weeks. The mean results of all 
outcome measures are presented in Table 3. The descriptive statistics show some improvements 
starting at 12 weeks after injection (around the end of the physical therapy program). Outcome 
measures did not improve after 6 weeks compared to baseline.
At 26 weeks follow-up four of the five patients indicated that they would positively recommend 
this treatment to family or friends with the same injury.
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Table 3. Mean results of a PRP injection followed by a physical therapy program (n=6) 

























Pain (VAS) during ADL (0-100 mm) 27 (3-50) 22 (13-31) 9 (-2-21) 8 (-3-19) 7 (-7-21)
Pain (VAS) during 1x SLDS (0-100 mm) 33 (19-47) 27 (7-47) 10 (-5-25) 9 (-2-19) 9 (-5-23)
Pain (VAS) during 10X SLDS (0-100 mm) 47 (29-66) 43 (26-60) 26 (12-39) 18 (3-34) 15 (-3-34)
Pain (VAS) during maximal jump test 
(0-100 mm)
37 (6-67) a 8 (-7-23) 8 (-7-23) 13 (-9-35)
Pain (VAS) during triple-hop test 
(0-100 mm)
36 (11-61) a 12 (-1-26) 14 (0-28) 14 (-3-31)
a No jumps allowed in this stage of the physical therapy program
Discussion
The main aim of this study was to describe a post-injection physical therapy program for patellar 
tendinopathy patients. This is, to our knowledge, the first paper that extensively describes a post-
injection physical therapy program. The combined treatment of a PRP injection followed by a 
physical therapy program seems to be feasible. This case series further shows promising results of 
this combined treatment.
An important role exists for a physical therapy program after PRP injection treatment in patellar 
tendinopathy patients, because a mechanical loading is needed after this injection.16 As proposed 
in the literature,6 the rehabilitation of patellar tendinopathy is aimed at improving muscle-tendon 
function and normalising the pelvic/lower limb kinetic chain. The post-injection physical therapy 
program therefore includes training muscle strength, endurance and power, and retraining sport-
specific function.6
Rationale physical therapy program
The first phase of the physical therapy program starts with informing and advising the patient 
about the content and rationale of the program. As walking can be painful after an injection in the 
patellar tendon, a splint can be used to reduce pain and crutches can be used to facilitate walking 
in the first days. The first few days after injection, rest, walking with crutches and only a low load 
are indicated because an injection causes some damage to the tendon and the tendon needs to 
‘calm down’. The effects of platelets are present in the first days after injection without the need 
for mechanical loading.16 Furthermore, in usual treatment of patellar tendinopathy the load on the 
patellar tendon is lowered first before increasing it again.6,23 Additionally, cryotherapy can be used 
by the patient to reduce pain in the first days after injection.24 The program starts with increasing 
activities of daily living and low-load exercises a few days after the injection, so the patient will 
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not be completely immobilised. This is supported by a laboratory study from Virchenko et al.,16 
who state that complete unloading after an injection with PRP could impair the healing process. 
They hypothesised that early mechanical loading by physical therapy is needed to benefit from 
the inflammatory response induced by the PRP injection.
The second phase is characterised by more dynamic and active exercises than the first 
phase. Intensity is increased and exercises are prescribed in the home exercise program with 
mounting complexity to improve the entire kinetic chain.6 Patients familiar with long-term patellar 
tendinopathy symptoms have generally shown a moderate coordination of the lower extremities 
and atrophy based on disuse developed in time.6,25 For this reason, the rehabilitation starts with 
exercises to improve coordination and strength endurance. This is intended to be achieved 
through many repetitions in closed-chain exercises.26,27
Eccentric training is currently the best-evidence treatment for patellar tendinopathy.5,8,28 
According to the assumed working mechanism, a PRP injection should always be combined 
with mechanical loading.14,15 Eccentric exercises should therefore be included in a post-injection 
physical therapy program, even though all patients performed an eccentric exercise program in 
the past. The eccentric exercises are integrated into phase 3 of the program (around week 5 after 
injection). Eccentric exercises are performed only twice a week in this phase of the program, to 
give the tendon time to adapt; after this phase the load on the tendon is gradually increased 
further to augment its load capacity. Although eccentric training plays an important role in the 
physical therapy program, this is combined with exercises which include concentric training. 
Results of concentric and eccentric heavy slow resistance training compared to solely eccentric 
training appear to be similar.29 The combination of concentric and eccentric training is used to 
train the entire kinetic chain and might promote collagen synthesis.29 Leg extensions in open chain 
exercises are avoided in the first 3 phases of the program, because a high load on the tendon was 
found in the last ±10˚ of knee extension and the load on the tendon is gradually increased in the 
physical therapy program.30
Core muscles are important in the load distribution on the patellar tendon,6 therefore core 
stability exercises are also integrated starting in the third phase of the program. Various other 
exercises are also integrated into the program to increase load capacity of the lower extremity.6,23
Phase 4 consists mainly of daily eccentric training based on the protocol proposed by Alfredson.31 
The eccentric training consists of single-leg squats performed on a decline board (25°).7,32 It seems 
that some pain is needed and therefore acceptable during the eccentric exercises for them to 
be effective,7 but no studies exist that specify an optimal level of discomfort/pain during the 
execution of these exercises. In this program, pain during eccentric training should not exceed 50 
on the VAS scale (0-100), which has been demonstrated to be a reasonable approach in Achilles 
tendinopathy.33
Since walking and running are an essential part of daily activities and most sports, this needs to 
be included in a physical therapy program. Running and walking exercises of increasing intensity 
and difficulty are part of the integration phase of the physical therapy program.6 The run-and-walk 
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exercises start around the 7th week of the program with interval walking/jogging advancing to 
multidirectional running. To further increase the load capacity of the tendon, jump exercises with 
increasing difficulty and sport-specific exercises are also started in this phase.6 In the final phase 
the exercises become increasingly sport-specific, as every sport has its own demands and the 
program is aimed at returning to sports.34
There is extensive debate on physical therapy programs, which often differ per therapist due to 
a lack of thorough research on aspects of the program and experiences of the physical therapist. 
This study tried to cluster pragmatic and theoretical knowledge into one physical therapy program 
which can be used for patellar tendinopathy patients after a PRP injection treatment. There is a 
scarcity of research, for example, on the length of the rest interval between sets of exercises. 
The exercises in this program are performed with a rest interval of 30-60 seconds to promote 
muscular hypertrophy.35 Multiple sets of exercises are performed because this is more effective 
than single sets.36 This program’s support from the literature, combined with sports medicine 
expertise, shows its suitability as a physical therapy program after PRP injection treatment. The 
program might also be suitable to follow other injection treatments like autologous blood and dry 
needling, because of their comparable working mechanism.
Feasibility
The combined treatment of a PRP injection followed by a physical therapy program seems 
feasible because neither patients nor practitioners reported complications. Further, a self-
reported compliance with the program of 7.0 (0-10) was indicated in the diaries. This seems to be 
a fair number; by comparison, previous research reports compliance with an eccentric exercise 
program of 60-65%.37
First results
It is important to state that due to several limitations of this case-series, no well-grounded 
statements can be made on the effectiveness of the treatment. Limitations are the small number of 
participants and lack of a control group. Another limitation is the heterogeneity of the participants. 
Four unilateral and one bilateral patient were treated. A second injection in the other knee two 
weeks after the first injection might have interfered with the rehabilitation in the bilateral patient. 
Finally, men as well as women were included.
While keeping these limitations in mind, the data show mainly positive results after treatment. 
Five of the six treated knees show improvement in outcome measures and patients would 
recommend this treatment to family or friends. It is remarkable that the only patient who did not 
show improvement after treatment was the one with the lowest self-reported program compliance. 
Three patients with the highest self-reported compliance showed the largest improvement in 
VISA-P score. This is in accordance with a pilot study on PRP from Kon et al.;17 poorer results of 
a PRP injection were obtained when compliance was low. More research is needed to obtain 
full insight into the results of PRP combined with physical therapy and the additional value of 
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the combination of treatments over one treatment alone. Currently, the results of PRP treatments 
have not yet been extensively studied, and results of the few high-quality studies conducted are 
contradictory.13,38
Final reflections and future research
This study can be an important guideline for physical therapists in the rehabilitation of patients 
with patellar tendinopathy after an injection with PRP. A physical therapy program, based on 
current insight in literature and expert opinion, after PRP injection is extensively described and 
underpinned in this article. This study proposes a combination treatment of an injection with 
PRP followed by a physical therapy program. The combination seems to be required, because a 
previous eccentric exercise physical therapy program and other treatments alone did not result in 
positive effects. The healing of a tendinopathic tendon is an interplay of mechanical and biological 
factors.8,12 This supports use of a multifactorial approach with more than one treatment modality 
for patients in the late/degenerative phase of patellar tendinopathy. An implication of a combined 
treatment and design used in the study is that this case-series does not provide evidence for an 
effect of this treatment or one of its components; it provides only initial insight into the outcome 
of a combined treatment of PRP injection together with a physical therapy program which results 
seem promising.
It is important for further research to standardise post-injection physical therapy programs. 
A  clear description of a program is needed to compare effects of different programs. Future 
research needs to address this to investigate the best injection treatment and subsequent physical 
therapy program. Ideally, standardised physical therapy programs, like the program described in 
this study, need to be compared in randomised clinical trials.
Conclusion
A post-PRP injection physical therapy program was described in this study. This is, to our 
knowledge, the first study to extensively describe an exercise based physical therapy program 
after an injection treatment for patellar tendinopathy patients that is based on current literature 
insights and expert opinion. The study demonstrated feasibility of the combination treatment. 
The combination treatment reported in this study seems to be promising for patients in the late/
degenerative phase of patellar tendinopathy.
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Aim of this thesis was to gain more insight into the development and treatment of patellar 
tendinopathy. The effect of loading on patellar tendon structure in adolescent volleyball athletes 
was determined in chapter 2. It was found that tendon structure on UTC did not change during 
the course of a 5 day volleyball tournament. Secondary analyses showed that the effect of 
cumulative loading over 5 days may be different for athletes with pre-existing hypoechoic 
abnormalities on ultrasound; a trend was found that athletes with hypoechoic abnormalities at 
the start of the tournament show a decrease in stability of patellar tendon structure on UTC during 
the tournament.
The effect of two new exercise-based physical therapy programs for in-season management 
of patellar tendinopathy on pain and tendon structure was determined in chapters 3 and 4. The 
randomised clinical trial presented in chapter 3 showed that both isometric and isotonic exercise 
programs reduce pain and improve function for patients with patellar tendinopathy while 
in-season. Chapter 4 found that a 4-week exercise program which decreased pain had no effects 
on tendon structure quantified by UTC. Pain reduction and improvement of function were not 
found to be related to tendon structure on UTC after a 4-week exercise program.
In chapter 5 and 6 the role of exercise-based physical therapy and injection in patellar 
tendinopathy treatment was determined. The systematic review in chapter 5 showed that all seven 
different injection treatments showed positive results in the treatment of patellar tendinopathy. 
This has to be interpreted with caution as mainly low quality studies were included in the review. 
It was demonstrated that corticosteroid injections are an exception to the positive results of 
injection treatments; a relapse of symptoms was found in all three randomised controlled trials 
investigating corticosteroid injections. Besides corticosteroid injections, it does not seem to 
matter what is injected in a pathological patellar tendon. Tendons seem to improve with every 
injection, but this may also be a result of the post injection rehabilitation program. One of the other 
findings of the systematic review was that all studies used a post injection exercise program and 
emphasised the importance of such a program for a beneficial outcome of treatment. However, 
the exercise programs were poorly described in the existing literature. Therefore, an evidence 
and best practice based post injection exercise program was described in chapter 6. The exercise 
program was found to be feasible and first results of the combination of a platelet-rich plasma 
injection with this exercise program were mainly positive.
In this general discussion the results of the different studies are discussed in a broader 
perspective. First, the effect of loading on patellar tendon structure is discussed. Second, a 
discussion around ultrasound tissue characterisation is provided followed by a discussion on 
management of patellar tendinopathy. Finally, physical therapy research is discussed and this 
chapter ends with clinical implications, future research suggestions and conclusion of this thesis.
Van_Ark.indd   105 14-8-2015   16:26:03
Chapter 7
106
A story from the field – clinical diagnosis
You start with a thorough interview and examination of the 24 year old volleyball player 
who presents to you. The interview reveals that symptoms began 8 years ago when he 
started to participate in training sessions and games of a higher age group next to his own 
team. Last weeks training intensity has increased in preparation for the upcoming play-
offs. He experienced the same symptoms at the end of last year’s season and was treated 
with extracorporeal shockwave therapy during the last weeks of the season; pain did not 
decrease from this treatment. When he stopped playing after finishing the season, pain 
decreased. He experiences load related focal pain near the apex of the patella. Physical 
examination shows wasting of gastrocnemius and quadriceps muscles. Furthermore, 
palpation of the inferior pole of the patella is painful. A single leg squat on a decline board 
(25⁰) results in a 7 out of 10 pain score on a numeric rating scale. Interview and physical 
examination lead you to the clinical diagnosis of patellar tendinopathy.
Effect of loading on patellar tendon structure
The first aim of this thesis, determining the effect of loading on patellar tendon structure 
in athletes, was investigated in chapter 2. Main conclusion of this chapter was that tendon 
structure of the patellar tendon on UTC does not change during a 5-day volleyball tournament 
in adolescent athletes. This suggests that in general (adolescent) tendons can withstand high 
amounts of load. Several factors in addition to training volume and number of games1 may exist 
that make a person more vulnerable to develop abnormalities in a tendon. Examples of features 
which can increase the chance of developing tendinopathy are: adiposity2, gene composition 
(e.g. COL1A1 and COL5A1)3, reduced dorsiflexion range of the ankle4,5, stiffer landing strategy6,7, 
higher jump capacity8, fluoroquinolone use9 and limited quadriceps and hamstring flexibility10. 
Someone with (a combination of) these features at the time of relatively high tendon loading is 
likely to be prone to develop pathology in the patellar tendon. At a different point in time, the 
same person with changed features may be more or less prone to develop pathology. Chapter 2 
also showed that the presence of hypoechoic abnormalities before loading seems to predispose 
these tendons to developing a more disorganised tendon structure. These participants may 
already have more features that increase the chance of developing abnormalities at baseline. The 
fact that similar loading can lead to different responses of the patellar tendon is corroborated by 
a study investigating ultrasound images of volleyball players before and after a season. This study 
showed that 29% of the participants had a change in tendon abnormality at the end of the season 
compared to the start of the season. 25% developed abnormalities, and tendon abnormalities 
disappeared in 4% of the participants.11 Studies with large numbers of participants are needed 




to gain further insight in the effects of different individual features in combination with load on 
patellar tendon structure.
Next to in-vivo studies, basic studies have investigated the effects of tendon loading. 
Communication between tendon cells in response to mechanical loading takes place by 
mechanotransduction.12 Studies on protein (precursors) and gene expression in blood or tendon 
tissue after loading showed increased and decreased collagen synthesis with increased and 
decreased loading respectively.13,14 An increase of hydroxyproline, a protein specific for collagen 
synthesis, was demonstrated already six hours after exercise.15 Other in-vitro and ex-vivo studies 
confirm that collagen synthesis increases after mechanical loading of a tendon.13 On the other 
hand, degradation of collagen is also increased after exercise, matrix metalloproteinases (MMPs), 
responsible for degrading ECM proteins, are increased in the Achilles tendon after one hour of 
treadmill running.16 Growth factors, in particular Transforming Growth Factor-β–1 (TGF-β–I) and 
Insulin-like Growth Factor (IGF-I), seem to play an important role in tendon adaptation to loading.13,17 
These in-vitro and ex-vivo studies on loading response of tendons have to be interpreted with 
care, loads applied to a tendon often do not match in-vivo loads and often only a single aspect of 
a tendon is investigated.18 Real-life in-vivo studies such as the ones in this thesis are important to 
understand the effects of genuine tendon loading.
Altogether, the effect of loading of the patellar tendon on tendon structure is multifactorial. 
It seems to be more than just training volume and competition load1 that determines if tendon 
structure is affected after loading. Based on current research it can be stated that in general 
a patellar tendon of adolescent athletes may be able to withstand ‘high tendon load’, such as 
cumulative days of playing matches, before tendon structure is affected. The presence of factors 
such as hypoechoic abnormalities is likely to increase the chance of developing further changes in 
tendon structure. Knowledge of how a patellar tendon responds to load is important to eventually 
prevent development of patellar tendinopathy. Once we know the effects of different types of 
loading of different people in different settings, we may be able to change loads and/or change 
characteristics that negatively affect the patellar tendon. Therefore, more in-vitro, ex-vivo and 
especially in-vivo studies have to be conducted. Larger studies with different populations and 
multiple follow-up measurements on a regular basis are needed to be able to identify a specific 
load detrimental for a specific population.
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A story from the field – imaging
In your specialised tendon clinic you image his patellar tendon with ultrasound tissue 
characterisation. The UTC scan shows a thickened patellar tendon with hypoechoic 
abnormalities. An area of echo-type III near the apex of the patella surrounded by echo-
types I and II is observed. The scan confirms the clinical diagnosis of patellar tendinopathy. 
Based on the characteristics obtained in the interview and examination, you diagnose his 
symptoms as a reactive on degenerative patellar tendinopathy.
Imaging – UTC
Conventional ultrasound is user dependent and relies on subjective interpretation of images (van 
Schie, Klauser).19,20 Handling of the ultrasound probe and machine settings can have consequences 
for the size and presentation of hypoechoic areas. Furthermore, while structure of a tendon is 
obviously a 3-D matter, it can only be captured by 2-D images with conventional ultrasound.19 Part 
of the difficulty of conventional ultrasound is overcome with the introduction of ultrasound tissue 
characterisation (UTC), an ultrasound device specifically designed for tendons. As extensively 
described in chapters 2, 6 and previous publications,19,21,22 UTC uses an ultrasound probe fixed in 
a tracking device to take a transverse image of the tendon every 0.2mm. A 3-dimensional data 
block is created using the transverse images. The UTC imaging software (Stein, the Netherlands) 
compares stability of pixel brightness in the ultrasound data block of one pixel with the pixels 
around that pixel, which allows quantification of tendon structure in 4 echo-types. This cuts out 
some of the subjectivity of someone interpreting ultrasound images.
UTC provides more standardised images than regular ultrasound; features such as standardised 
gain, depth and focus point, and use of stability of brightness over multiple images increase 
repeatability of an ultrasound scan. The 3D ultrasound data block also facilitates the possibility to 
compare the exact location of abnormalities in a tendon. Although still some user dependency 
(e.g. movement artefacts) exists when performing UTC scans, having the ultrasound probe fixed 
in a machine standardises transducer tilt and rotational angle.
Determination of tendon structure with UTC, the primary outcome measure used in two of the 
studies in this thesis, seems valuable in studying and monitoring patellar tendinopathy. UTC has 
been shown to be able to discriminate between symptomatic and asymptomatic Achilles tendons 
in humans.19 It was also found to have a good inter-observer reliability in Achilles tendons19 and 
reliability for the patellar tendon was found to be promising in chapter 2. A link between UTC echo-
types and histopathology of tendons has been established in the superficial digital flexor tendon 
of horses: histopathology of tendon samples was matched to UTC echo-types of the same tendon. 
Echo-type I matches intact and aligned tendon bundles, echo-type II matches less integer and 
waving tendon bundles; echo-type III matches mainly fibrillary tissue; and echo-type IV matches 




mainly amorphous matrix with loose fibrils, cells or fluid.21 The superficial digital flexor tendon in 
horses is closely related to Achilles tendons of humans.23 Therefore, it can be expected that a link 
with histopathology is present in humans as well. However, to confirm this link further research 
is necessary to investigate if UTC echo-types can indeed be directly linked to histopathological 
changes. It is hypothesised that UTC images can distinguish different phases in the continuum 
model; reactive and degenerative tendons may be discriminated.24 This would have important 
implications for the treatment of patellar tendinopathy. The diagnosis could be specified, making 
a more individually tailored treatment possible. Future research should investigate the relationship 
between UTC image and different presentations (reactive or degenerative phase) of patellar 
tendinopathy.
It is important to take notice of UTC machine settings when interpreting studies using UTC. 
Since UTC has been in development over the last decades, several features of the machine have 
been changed over time. Early studies moved the ultrasound probe manually along the tendon 
instead of using an automated machine.19 Furthermore, the early release of the UTC has a different 
ultrasound probe (SmartProbe 10L5) compared to the current release of the machine (SmartProbe 
12L5-V). The part of the tendon of which the stability of echo pattern is quantified (window size) can 
also be varied. The studies in this thesis used window size 25, which corresponds with a distance of 
4.8mm over which the stability is calculated. A distance of 3.2mm or 1.6 mm can also be used; this 
can potentially influence the results. However, data from chapter 2 were also analysed with these 
different window size settings post-hoc. Although absolute values differed, changes in echo-type 
percentages over time were not different from other window sizes. An ongoing discussion around 
UTC machine settings exists; further research on this subject is necessary to finalise this discussion. 
Meanwhile it is essential that characteristics of UTC scans are always reported when reporting 
research or clinical data.
Technical developments have led to new imaging techniques which have potential value in 
clinical practice. Conventional B-mode ultrasound is currently the most used imaging technique 
for patellar tendinopathy. Besides UTC, several imaging techniques are currently developing to 
improve tendon imaging. An ultrasound technique that is still in its early days is elastography. 
Elastography is based on the strain (displacement) caused by external compression of the 
tendon.20 Elasticity of tendon relative to its environment is displayed as different colours placed 
on top of a B-mode ultrasound image. Preliminary research showed better diagnostic accuracy 
of elastography combined with B-mode ultrasound in Achilles tendinopathy compared to 
only B-mode ultrasound.25 However, elastography has similar limitations (2-D image and user 
dependency) as conventional ultrasound.26 Oher developments in imaging techniques are new 
MRI techniques with use of contrast agents.27 Main limitations are the cost of these imaging 
techniques and limited availability of MRI-scanners. Based on previously mentioned characteristics 
of UTC and its potential to detect small changes in a tendon in response to load28,29, UTC might be 
the best currently available tool to evaluate and monitor tendon structure in response to load, and 
it might increase the importance of imaging of the tendon. More research is needed to further 
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explore the possibilities of UTC and other imaging techniques to improve tendon imaging for 
clinical practice.
A story from the field – management
You start his treatment by educating the patient about the on/off nature of patellar tendon 
pain and the need for gradually building the capacity of the tendon. You explain that the 
pain is related to the load placed on the tendon: when he stops playing volleyball (e.g. off-
season), it is expected that the pain will decrease as well. However, pain is likely to return 
when load is increased in the pre-season. Capacity of the tendon needs to be increased 
by gradually increasing load through exercises; unfortunately treatment of this injury is no 
quick fix. For the final 4 weeks of current season you instruct him to perform an exercise 
program consisting of 4 exercise sessions per week on a leg extension machine (heavy 
weight isotonic/isometric exercises) to decrease pain. Subsequently, capacity of the patellar 
tendon needs to be increased in the off-season. Rehabilitation will be continued with slow 
speed, functional strength exercises. When strength is sufficient, speed is introduced into 
the program, and finally plyometric work is added. The kinetic chain is addressed during 
rehabilitation including muscle wasting of the gastrocnemius muscle. Especially in the 
early phases of return to sport, you indicate 2-3 days of relative rest between volleyball 
sessions.
Management
Management of patellar tendinopathy can be very difficult, a large range of treatment options 
exist with variable success rates.30 An important finding of this thesis was the possibility to 
decrease patellar tendon pain with exercise programs in-season (chapter 3). This is another piece 
of evidence supporting exercise as treatment for patellar tendinopathy. Previous studies have also 
outlined the importance of exercise programs in the treatment of this injury.31,32 Exercise seems to 
be the only treatment modality to positively influence the tendon on cellular level; in-vitro and 
ex-vivo studies have shown33 that mechanical loading positively influences mechanical properties 
of a tendon.13.
Establishing the phase of tendinopathy on the basis of the continuum model may be an 
important first step for the treatment of patellar tendinopathy.34 Clinically it is important to 
distinguish a reactive or degenerative tendinopathy. Recently a reactive on degenerative phase has 
been described as well35; this can be seen in a patient with underlying degenerative tendinopathy 
who overloaded his/her tendon. A patellar tendinopathy in the degenerative phase will need 
a different treatment than a patellar tendinopathy with a reactive component. The following 




paragraphs provide recommendations for the treatment of patellar tendinopathy based on the 
findings of this thesis (chapters 3-6) and current literature in the light of the continuum model.
Reactive patellar tendinopathy
A 4-week isometric and isotonic exercise program on a leg extension machine decreased pain in 
patellar tendinopathy patients (chapter 3). These programs can be particularly useful in reactive or 
reactive on degenerative tendinopathies, because these phases are characterised by a (sudden) 
increase in pain. Since it is not necessary to withdraw from training or matches during isometric 
and isotonic programs, these interventions may be very useful in the competing athlete. This is 
in contrast to the often studied eccentric exercise protocol of Alfredson,36 that causes symptoms 
to worsen or remain the same in prolonged tendon loading.37,38 Next to isometric or isotonic 
exercises, adjustment of load may be necessary when pain does not diminish. Load adjustment 
can for example be achieved by removing high load session(s) in a training week, or skipping part 
of a session in which repetitive explosive movements are performed.
It is important to realise that the investigated interventions aim to decrease pain in the short 
term. The training effect of muscle and tendon is only small considering the 4-week time period. 
Isotonic or isometric exercises may have a pain management function in-season or during the 
initial weeks after a patient first presents to a clinic. After the acute pain decreases it is necessary 
to continue with appropriate rehabilitation. Exercises solely on a leg extension machine, as in the 
investigated programs, will not be sufficient for continued rehabilitation. Refusing to continue 
with appropriate rehabilitation will likely lead to a continuation or worsening of pain symptoms. 
The following paragraphs will discuss some of the possibilities for appropriate rehabilitation after 
acute pain decreases by means of isotonic or isometric exercises and/or load adjustment.
Targeting deficiencies in the entire kinetic chain of a patient with patellar tendinopathy is an 
essential part of continued rehabilitation. A period with decreased sport activities, such as the off-
season, may be ideal to target these deficiencies. Reducing load in the off-season will likely cause 
symptoms to further decrease because there is simply no provocative load to trigger symptoms. 
Unloading of the tendon causes a reduced capacity of the tendon to withstand loads.18 As in every 
tendinopathy, it is essential that patellar tendinopathy patients are not completely immobilised. 
Immobilisation will lead to further reduction of the quality of tendon tissue.39 The (sudden) increase 
in load at the start of the new season may very well lead to a relapse of symptoms.
Ceasing or diminishing explosive movements which use the stretch-shorten cycle (SSC) in 
the first weeks off-season seems important to provide relative rest to the tendon and prevent 
further cumulative damage. This period is ideal to target strength deficiencies in the entire kinetic 
chain.24,40 Heavy resistance exercises at slow speeds are the preferred exercises in this phase to 
improve capacity of the stretch shorten cycle.24,41,42 When strength of the patient is sufficient, 
rehabilitation should progress to sport specific functional exercises and subsequently to ‘high 
tendon load’ exercise including skipping, running and controlled jumping to increase tendon 
capacity. Finally, more fast contractions should be integrated in the program (more use of SSC). 
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Timing of sessions during the rehabilitation is important. Tendons need time to adapt43,44, days 
between training sessions and timing of training before competition is crucial, 2 or 3 days of 
relative rest may be needed.
As outlined before, the exact way in which exercise-based physical therapy programs reduces 
pain is not known. Indeed, it is still unknown what causes pain in (patellar) tendinopathy. It has 
physiological as well as pathophysiological characteristics.45. Focal pain and pain related to load 
are physiological characteristics of tendon pain, other pathophysiological characteristics are that 
pain has no direct link with abnormalities in the tendon, pain can persist for years and there is no 
inflammation with a clear end point.45 Hypotheses about the origin of pain in tendinopathy are 
both peripheral (e.g. matrix, vascular or tenocyte changes) as well as central (e.g. sensitisation) 
mechanisms.45,46 More knowledge on pain in tendinopathy can lead to application of this 
knowledge in treatments. Therefore, more basic science on pathophysiology and origin of pain in 
tendinopathy is needed to increase knowledge on this subject.
Degenerative patellar tendinopathy
When dealing with an ongoing degenerative patellar tendinopathy, a multi-dimensional treatment 
approach is a good option. An exercise-based physical therapy program may be combined with 
other treatments; one of the options is an injection in the patellar tendon. Since a post injection 
exercise program consists of an adjustment of the load followed by a gradual increase in load, 
one might argue that the achieved results can be ascribed to the exercise program alone. On the 
other hand, in most studies investigating injection treatments, one of the inclusion criteria was 
that previous, often unspecified, conservative treatment was not successful. When choosing an 
injection treatment, it does not seem to matter (except for corticosteroids) what is injected in the 
tendon (chapter 5). Although different types of injection treatment have different rationales such as 
attenuating pain or facilitating regeneration (chapter 5), it might be the penetration of the tendon 
with a needle itself that is effective. Injecting in the tendon may result in an inflammatory reaction 
of the tendon which can be beneficial in a degenerative tendon.47 This might start regeneration 
of collagen in the degenerative area of the tendon. In contrast, as put forward in chapter 4, 
remodelling tendon structure might not be needed for pain reduction during rehabilitation; this 
questions the additional value of an injection into the degenerative area of the tendon. An array 
of injections is available on the market, for example many different kits are on sale to produce 
various forms of platelet-rich plasma. Based on the review in this thesis (chapter 5) choosing a 
far more expensive platelet-rich plasma injection does not seem to have additional benefit over 
other much cheaper injections. This seems to be supported by a randomised controlled trial in the 
Achilles tendon comparing platelet-rich plasma with a saline injection.48
Physical therapy – clinic and research
This thesis contains research on real-life loading of athletes and interventions for patients with 
patellar tendinopathy. Conducting research on athletes and patients in real-life situations comes 




with limitations. One of the major difficulties of this kind of research is controlling the environment. 
For instance, it is not possible to measure the exact load placed on a tendon over a time period, 
load on a tendon will always be an estimate; for example, based on number of jumps and landings, 
hours participating in sports and/or subjective loading of a participant. Furthermore, restricting 
or imposing behaviour of participants in daily activities and/or sports may be hard, especially in 
longer term interventions; and it can be difficult to do measurements outside a lab setting.
A treatment should be tailored to a specific case; ‘one size does not fit all’49,50. Exercise 
programs and other treatments described in this thesis should thus not be used as a recipe for 
all patients with patellar tendinopathy. Many differences such as phase of tendinopathy (reactive 
or degenerative) and loading history exist between patients. In contrast to the importance of 
an individually tailored treatment for patellar tendinopathy, participants within a study group in 
scientific research receive, by definition, the same treatment to be able to make statements on 
that specific treatment. Clinical practice and scientific research in physical therapy might thus 
seem conflicting. A critic might say ‘why are we doing this clinical physical therapy research? We 
have to treat every patient differently anyway’. However, advantages of real-life clinical studies 
outweigh the limitations involved in conducting such studies. Clinical research in (exercise-based) 
physical therapy is essential to obtain reliable knowledge on application of basic research and 
effects of specific treatments in practice.51 When we do not study and present results on physical 
therapy treatments, treatment in clinical practice will just be based on personal experiences of 
clinicians.52 It is important to obtain a good understanding of the features (e.g. type of exercise, 
weights, duration of a program, etc.) that are important for a successful (patellar tendinopathy) 
treatment. High quality scientific studies are needed for a better treatment and an optimal 
recovery of the patient; this may also contribute to a reduction of healthcare costs. The studies in 
this thesis have a high degree of ‘real-life’ situations and clinical applicability. Due to the nature of 
the studies, translation of this research into clinical practice is fairly easy and contributes to current 
treatment of patellar tendinopathy. Clinical research in (exercise-based) physical therapy should 
be expanded in the future.
A story from the field – results
The volleyball player was able to play with fewer symptoms during the final weeks of the 
play-offs. Partly due to his contribution his team won the championship. His off-season 
rehabilitation should lead to a prevention of recurrence of patellar tendinopathy symptoms 
during the next season. A prevention program in the off-season of the following seasons 
might be needed to prevent return of symptoms in the long term.




The following clinical implications of this thesis in a broad perspective can be provided:
• Exposing healthy (adolescent) tendons to consecutive days of loading is in general not 
detrimental for structure of adolescent patellar tendons. Individual risk factors such as presence 
of hypoechoic abnormalities may cause a decrease in patellar tendon structure from the same 
load.
• Heavy load isometric and isotonic exercise programs can contribute to reducing symptoms of 
patellar tendinopathy. A decrease in symptoms after a 4-week exercise program does not have 
a direct link to structural change of a patellar tendon.
• Injection treatments are an option in the multidimensional treatment of patellar tendinopathy. 
Type of injection (except corticosteroid injection) does not seem to matter for outcome of a 
treatment.
• A post injection exercise-based physical therapy program seems to be important when 
choosing for an injection treatment.
Suggestions for future research
More work in the field of patellar tendinopathy is required to ensure a successful treatment and to 
be able to decrease the prevalence of this hard to treat injury. An outline of recommendations for 
future research, some previously mentioned, is provided below:
• To establish the critical load for tendon structure change, effects of loading should be further 
investigated in in-vivo studies. Studies should focus on the effects of acute high bouts of 
loading as well as cumulative loading on tendon structure, with structure measured at regular 
intervals. Tendon structure can be monitored with UTC or other evolving imaging techniques.
• The effects of the same loading on tendon structure in different populations (different set of 
risk factors) with different loading histories should be investigated as well. For example, effects 
of loading on tendon structure of athletic versus inactive individuals. Larger studies are needed 
to determine risk factors for tendon structure change.
• The long term effects of isometric and isotonic exercises on clinical outcomes and tendon 
structure should be investigated in future studies
• Studies that explore the effects of exercise programs on pain and function should be 
prominent in upcoming patellar tendinopathy research. Different characteristics (e.g. type of 
exercises, weights, duration of program and pain during exercises) of exercise programs should 
be further investigated. Next to clinical outcomes, effects of exercise programs on tendon 
structure, tendon dimensions, muscular strength and changes to the central nervous system 
should be further investigated.
• The possibilities of UTC need to be further investigated and used in research to study the 
relation between UTC images and different clinical presentations of patellar tendinopathy.




• Special attention should be paid to post injection (exercise) programs when investigating 
injection treatments. Injection treatments for patellar tendinopathy should be further 
investigated in high quality (randomised controlled) studies.
• Basic science to establish the exact pathophysiology and origin of pain in patellar tendinopathy 
is needed to underpin treatments and prevention of this injury.
Conclusion
In general, patellar tendon structure of an adolescent athlete does not seem to be affected during 
cumulative days of loading; the presence of hypoechoic abnormalities in a tendon might result 
in a different tendon response. Exercise-based physical therapy is an important component of 
patellar tendinopathy management; exercises can decrease pain, even when load is not adjusted. 
Athletes with patellar tendinopathy in-season can benefit from isometric or isotonic exercises, 
even though structure is not affected. Injection treatments might be of additional value in the 
multi-dimensional treatment of patellar tendinopathy; it does not seem to matter (corticosteroids 
excepted) what is injected in the tendon. Although it is a utopia to believe that findings of this 
thesis will make patellar tendinopathy treatment easy, it provides important new knowledge for 
its treatment, guidelines for clinical practice and directions for future research.
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Summary
Patellar tendinopathy, commonly known as jumper’s knee, is an overuse injury of the patellar 
tendon with a high prevalence. It is particularly seen in jumping athletes such as volleyball and 
basketball players, and can have a major impact on sports and even work participation. Aetiology 
and pathophysiology of patellar tendinopathy are still not fully elucidated. Management of 
patellar tendinopathy is often challenging; many different treatments with variable outcome 
are currently being used. The general aim of this thesis was to investigate the development and 
management of patellar tendinopathy. Specific aims were: 1. To determine the effect of loading 
on patellar tendon structure in athletes; 2. To determine the effect of two new exercise-based 
physical therapy modalities for in-season management of patellar tendinopathy on pain and 
tendon structure; and 3. To determine the role of exercise-based physical therapy and injection in 
patellar tendinopathy treatment.
The first aim of this thesis, determining the effect of patellar tendon loading on tendon 
structure, was investigated in Chapter 2. The patellar tendons of adolescent volleyball athletes 
(aged 16-18) were scanned with ultrasound tissue characterisation (UTC) on every day of a five-
day volleyball tournament in which they participated. Results showed that tendon structure on 
UTC (echo-types I and II) did not change during the course of the tournament. A trend was found 
for athletes with hypoechoic abnormalities at the start of the tournament, showing a decrease in 
patellar tendon structure on UTC during the tournament.
The effects of two new exercise-based physical therapy modalities for in-season management 
of patellar tendinopathy were determined in Chapters 3 and 4 (second aim). Chapter 3 focussed 
on clinical outcome. Volleyball and basketball players with a diagnosed patellar tendinopathy who 
played or trained at least three times per week were included in a randomised clinical trial. They 
were randomised into an isometric or an isotonic exercise program. Both groups performed a 
4-week exercise program with exercises on a leg extension machine four times per week. The 
isometric and isotonic exercise programs were matched for time under tension. Level of pain as 
indicated on a numeric rating scale (NRS) during a single-leg decline squat, a provocative clinical 
test to monitor tendon pain, was the primary outcome measure. A total of eight athletes in the 
isometric group and eleven athletes in the isotonic group completed the exercise program and 
all measurements. Median (interquartile range) NRS pain scores improved significantly over the 
4-week intervention period within the isometric group at 6.3 (5.3-7.0) to 4.0 (2.0-5.0) and within the 
isotonic group at 5.5 (4.0-6.0) to 2.0 (1.0-3.0). There was no significant difference in NRS pain score 
change between the two groups.
The effects of the exercise programs on patellar tendon structure using UTC were studied in 
Chapter 4. Before and after the exercise program, the patellar tendons of the participants were 
scanned with UTC to assess tendon structure and dimensions. Echo-types, anterior-posterior 
thickness and mean cross sectional area did not change after the 4-week exercise program. It can 
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be concluded from Chapters 3 and 4 that, in contrast to previously studied exercise programs, 
both of these exercise programs showed a decrease in pain in-season without adjustment of 
sport activities. A 4-week isometric or isotonic exercise program did not change tendon structure 
or dimensions on UTC, despite a pain decrease and function improvement.
In Chapters 5 and 6 the role of exercise-based physical therapy and injection in patellar 
tendinopathy treatment was determined (third aim). Chapter 5 is a systematic review of the 
literature on injection treatments for patellar tendinopathy. Studies on seven different injection 
treatments were found in the literature search, all with positive results, although this should 
be interpreted with caution as mainly low-quality studies were included in the review. It was 
demonstrated that corticosteroid injections are an exception; a relapse was found in all three 
randomised controlled trials investigating corticosteroid injections. In short, corticosteroid 
injections are detrimental in the treatment of patellar tendinopathy. Other injection treatments 
seem to be quite beneficial irrespective of the type of injection, yet these positive outcomes 
might also be explained by the post-injection rehabilitation program. All studies used a post-
injection exercise program and emphasised the importance of such a program for a beneficial 
outcome of treatment. Contrary to expectations, the exercise programs were only poorly 
described in the existing literature. Chapter 6 does provide an evidence- and best-practice-based 
post-injection exercise program. This program is characterised by a work-up of muscle strength, 
endurance, power and sport-specific function. The effects of a platelet-rich plasma injection in 
combination with this exercise program were investigated in five patellar tendinopathy patients 
(six tendons) who were recalcitrant to previous conservative treatment. The program was found 
to be feasible and first results of the combined platelet-rich plasma injection with this exercise 
program were mostly positive. Five of the six tendons showed an improvement after 26 weeks of 
at least 30 points on the VISA-P (Victorian Institute of Sport Assessment – Patella), a questionnaire 
assessing the severity of pain and function limitation.
Results of the previous chapters are put into a broader perspective in the general discussion 
in Chapter 7. Multiple factors that influence the effect of tendon loading on tendon structure are 
discussed, as is the imaging of tendons with UTC. The management of patellar tendinopathy is 
subsequently reviewed based on the results of this thesis and current insights from the literature. 
Reactive and degenerative tendinopathy are distinguished for purposes of management of 
patellar tendinopathy. The importance of clinical research in exercise-based physical therapy is 
also discussed, and clinical implications and suggestions for future research are proposed. One of 
the main clinical implications of this thesis is that heavy-load isometric and isotonic exercise 
programs can contribute to reducing symptoms of patellar tendinopathy. Corticosteroid injections 
are detrimental in the treatment of patellar tendinopathy, while other injections can be an option 
as part of its multidimensional treatment, however positive outcomes may also be the result of a 
post-injection rehabilitation program.
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Nederlandse samenvatting
Patella tendinopathie, ook wel bekend als jumper’s knee, is een veel voorkomende 
overbelastingsblessure van de kniepees. Het komt met name voor bij springsporters zoals 
volleyballers en basketballers en kan een grote impact hebben op sport- en zelfs werkparticipatie. 
Patella tendinopathie is een blessure die langdurig klachten kan geven en moeilijk te behandelen 
is. Ondanks een toename van onderzoek op gebied van tendinopathieën is het nog steeds niet 
duidelijk hoe een patella tendinopathie ontstaat en wat de beste behandeling ervan is. Het 
algemene doel van dit proefschrift was meer inzicht te krijgen in de ontstaanswijze en behandeling 
van patella tendinopathie. Specifieke doelen waren: 1. Het bepalen van het effect van belasting op 
structuur van de patellapees; 2. Het bepalen van het effect van twee nieuwe fysiotherapeutische 
oefenprogramma’s voor de behandeling van patella tendinopathie op pijn en structuur van de 
pees tijdens een seizoen; en 3. Het bepalen van de rol van fysiotherapeutische oefentherapie en 
injectiebehandelingen op patella tendinopathie.
Het eerste specifieke doel, het bepalen van het effect van belasting op de structuur van de 
patellapees is onderzocht in hoofdstuk 2. De structuur van de patellapees van adolescente 
volleyballers (16-18 jaar) werd tijdens het spelen van een volleybaltoernooi vijf achtereenvolgende 
dagen gemeten met een relatief nieuwe beeldvormende techniek voor pezen, genaamd 
ultrasound tissue characterisation (UTC). Deze studie toonde aan dat structuur van de patellapees 
van adolescente volleyballers gemeten met UTC (echo-types I en II) over het algemeen niet 
verandert gedurende vijf cumulatieve dagen van belasting van de pees. Wanneer er hypo-
echogene zones in de patellapees aanwezig waren voor aanvang van de belasting kan cumulatieve 
belasting over meerdere dagen wel leiden tot een verdere disorganisatie van de structuur van de 
patellapees (trend).
Hoofdstukken 3 en 4 hadden als doel om de effecten van twee fysiotherapeutische 
oefenprogramma’s ter vermindering van pijn tijdens een seizoen te onderzoeken (tweede doel). 
Een gerandomiseerd klinisch onderzoek waarin volleyballers en basketballers met een patella 
tendinopathie tijdens een seizoen deelnamen is beschreven in hoofdstuk 3. De deelnemers 
trainden of speelden ten minste drie keer per week en volgden na randomisatie een isometrisch 
of een isotonisch oefenprogramma. Het oefenprogramma duurde 4 weken waarin 4 keer per week 
oefeningen op een leg extension apparaat werden uitgevoerd. De duur van de spiercontracties 
tijdens de isometrische en isotonische oefeningen was gelijk voor beide de groepen. Pijn op 
een numeric rating scale (NRS) tijdens een single leg decline squat, een provocatieve klinische 
uitkomstmaat om pijn aan de patellapees te monitoren, was de belangrijkste uitkomstmaat. Deze 
nam significant af in zowel de isometrische als isotonische groep. Deelnemers die het isometrische 
programma (n=8) hadden gevolgd, lieten een vermindering van de pijn van 6.3 (5.3-7.0) naar 
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4.0 (2.0-5.0) (mediaan (interquartile range)) zien; de isotonische groep (n = 11) liet een afname van 
5.5 (4.0-6.0) naar 2.0 (1.0-3.0) zien (mediaan (interquartile range)). Er was geen significant verschil in 
pijnafname (NRS) tussen de isometrische en isotonische groep.
De effecten van deze 4 weken durende oefenprogramma’s op afmetingen en structuur van 
de patellapees gemeten met UTC werden onderzocht in hoofdstuk 4. In deze studie werd een 
UTC scan gemaakt voorafgaand en na afloop van het hiervoor beschreven 4 wekende durende 
oefenprogramma om de structuur en omvang van de patellapees te bepalen. Zowel de echo-
types, dikte als gemiddelde oppervlakte van de pees veranderden niet na 4 weken. Uit de 
hoofdstukken 3 en 4 kan worden geconcludeerd dat, in tegenstelling tot eerder onderzochte 
oefenprogramma’s tijdens een seizoen, zowel een isometrisch als isotonisch fysiotherapeutisch 
oefenprogramma van 4 weken de pijn van sporters met een patella tendinopathie tijdens een 
seizoen kan verlichten zonder aanpassing van de sportbelasting. Ondanks een verbetering van 
pijn en functie heeft een 4 weken durend isometrisch of isotonisch oefenprogramma geen 
(direct) effect op de structuur en omvang van de patellapees op UTC.
De rol van fysiotherapeutische oefenprogramma’s en injectiebehandelingen voor patella 
tendinopathie werd onderzocht in hoofdstukken 5 en 6 (derde doel). In hoofdstuk 5 is een 
systematische review van de literatuur over injectie behandelingen beschreven. Deze review 
liet zien dat alle zeven bestudeerde injectiebehandelingen een positief resultaat lieten zien in 
de behandeling van patella tendinopathie. Een voorzichtige interpretatie van deze resultaten is 
echter wel noodzakelijk aangezien voornamelijk studies van een lage kwaliteit beschikbaar waren. 
Een uitzondering op de positieve resultaten is een injectie met corticosteroïden; een terugkeer van 
de symptomen trad op bij alle drie gerandomiseerde en gecontroleerde studies die injecties met 
corticosteroïden onderzochten. Kortom, corticosteroïden injecties geven slechte resultaten in de 
behandeling van patella tendinopathie, de resultaten van andere injecties lijken allemaal positief. 
Deze positieve resultaten kunnen echter ook het resultaat zijn van het revalidatie programma na 
de injectie. Alle studies maakten gebruik van een oefenprogramma na de injectie en ook werd 
het belang van deze oefenprogramma’s benadrukt in diverse studies. In tegenstelling tot wat 
zou mogen worden verwacht, waren de oefenprogramma’s echter zeer beperkt beschreven. 
Om deze reden werd in hoofdstuk 6 een evidence- en best-practice based oefenprogramma 
specifiek voor na een injectiebehandeling van de kniepees beschreven. Dit programma bestaat 
uit een opbouw van spierkracht, uithoudingsvermogen, power en sportspecifieke functie. Naast 
de beschrijving van dit programma, werd een plaatjes-rijk plasma injectie in combinatie met 
dit oefenprogramma getest bij vijf patiënten (6 pezen) met een patella tendinopathie. Eerdere 
conservatieve behandelingen in deze groep patiënten waren niet succesvol. Dit oefenprogramma 
bleek goed uitvoerbaar en de eerste resultaten van een plaatjes-rijk plasma injectie gecombineerd 
met het oefenprogramma waren voornamelijk positief. Vijf van de zes patiënten lieten na een half 
jaar een klinisch relevante verbetering zien van ten minste 30 punten op de VISA-P score, een 
score op een vragenlijst naar ernst van de pijn en functie beperking.
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De resultaten van voorgaande hoofdstukken worden in de algemene discussie in hoofdstuk 7 
in een breder perspectief geplaatst. Er wordt hierin onder andere ingegaan op de verschillende 
factoren die van invloed kunnen zijn op verandering van peesstructuur en de beeldvorming van 
pezen met UTC. Vervolgens wordt de behandeling van patella tendinopathie op basis van de 
resultaten van dit proefschrift en de huidige inzichten in de literatuur behandeld. Hierbij wordt 
onderscheid gemaakt tussen reactieve en degeneratieve patella tendinopathie. Het belang 
van klinische studies in (oefentherapeutische) fysiotherapie wordt hierna besproken. Tot slot 
worden klinische aanbevelingen en suggesties voor vervolgonderzoek gedaan. Een van de 
belangrijke klinische aanbevelingen is dat isometrische en isotonische oefeningen met een zware 
belasting kunnen bijdragen aan de vermindering van symptomen van patella tendinopathie. 
Corticosteroïden injecties zijn nadelig in de behandeling van patella tendinopathie, overige 
injectiebehandelingen kunnen een optie zijn in de multidimensionale behandeling van patella 
tendinopathie waarbij het niet lijkt uit te maken wat er wordt geïnjecteerd. Positieve resultaten 
kunnen echter ook het gevolg zijn van het oefenprogramma na injectie.
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